literature review of neem tree pdf

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Ann Transl Med
• v.10(13); 2022 Jul

Exploring the therapeutic potential of Neem ( Azadirachta Indica ) for the treatment of prostate cancer: a literature review

Neelu batra.

1 Department of Pharmaceutical & Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA, USA;

Vigneshwari Easwar Kumar

2 Department of Biochemistry and Molecular Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA;

Roshni Nambiar

Cristabelle de souza.

3 Department of Pathology, Institute of Stem Cell Research and Regenerative Medicine, Stanford University, Stanford, CA, USA;

Ashley Yuen

4 Department of Urologic Surgery, University of California Davis, Sacramento, CA, USA;

5 Division of Hematology and Oncology, Department of Medicine, University of California Davis, Sacramento, CA, USA

Rashmi Verma

Paramita m. ghosh, ruth l. vinall, associated data.

The article’s supplementary files as

Background and Objective

Multiple studies have demonstrated the medical potency of plant extracts and specific phytochemicals as therapeutics for prostate cancer (PCa) patients. Of note, the Neem plant known for its role as an antibiotic and anti-inflammatory is underexplored with an untapped potential for further development. This review focuses on extracts and phytochemicals derived from the Neem tree (Latin name; Azadirachta indica ), commonly used throughout Southeast Asia for the prevention and treatment of a wide array of diseases including cancer. To date, there are more than 130 biologically active compounds that have been isolated from the Neem tree including azadirachtin, nimbolinin, nimbin, nimbidin, nimbidol, which have demonstrated a wide range of biological activities including anti-microbial, anti-fertility, anti-inflammatory, anti-arthritic, hepatoprotective, anti-diabetic, anti-ulcer, and anti-cancer effects. Very few scientific reports focus on the benefits of Neem in PCa, even though this herb has been used to prevent the disease and its progression for years in complementary and alternative medicine.

We used the search engines like PubMed, InCommon and Google using the key words: “Neem”, “Cancer”, “Prostate Cancer” and related words to find the information and data within the time frame from 1980–2022 for our article study.

Key Content and Findings

Here, we provide an overview of Neem extracts and phytochemical derivatives with a focus on their known potential and ability to inhibit specific cellular signaling pathways and processes which drive PCa incidence and progression.

Conclusions

The information presented here indicate that Neem and its derivatives have a therapeutic potential for the treatment of PCa when used as a single agent or in combination with conventional chemotherapeutics.

Introduction

Prostate cancer (PCa) is the most commonly diagnosed male malignancy and the fourth leading cause of cancer related male mortalities worldwide ( 1 , 2 ). Although PCa related fatalities have been declining, incidence rates have been on the rise with an increasing number of patients living with the disease ( 3 ). A significant number of PCa patients have used or are interested in using natural products to supplement their therapy, a move that is supported by a growing number of epidemiological, clinical, and pre-clinical studies ( 4 ), indicating lower toxicities, easier usage and greater availability in many cases, compared to pharmaceuticals ( 5 , 6 ). Multiple pre-clinical studies have reported the anti-cancer properties of Neem and Neem products in PCa cell lines and animal studies ( 7 - 14 ). Key pathways known to drive PCa progression include the androgen receptor (AR) and the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/Akt) pathway, both of which can be modulated by treatment with Neem and its derivatives. Pathways which are linked to chemoresistance (e.g., Bcl-2) are also targets of Neem and its derivatives.

Neem tree extracts and phytochemicals: an overview of general properties and clinical uses

The Neem tree is native to the Indian subcontinent and Burma. For hundreds of years, its various components and derivatives have been widely used in alternate medicine approaches, including Ayurveda, throughout South Asia and beyond ( 15 - 17 ). The Neem leaves, bark, seeds, flowers, and twigs have been reported to have anti-microbial, anti-inflammatory, anti-arthritic, hepatoprotective, anti-diabetic, anti-ulcer, and anti-cancer activities ( Figure 1 ) ( 13 , 17 - 29 ).

Important parts of the Neem tree ( Azadirachta indica ) and their therapeutic benefits.

Several clinical studies have tested the medicinal properties of Neem. For example, in a pilot study with 14 patients, Bandyopadhyay et al. ( 30 ) have demonstrated Neem bark extract to have therapeutic potential in controlling gastric hypersecretion and gastroduodenal ulcers. In this study, 30 mg of lyophilised aqueous extract of air-dried Neem bark was encapsulated in the gelatine capsule that was used for oral administration to the selected patients. Treatment with lyophilized Neem bark extract orally for 10 days at 30 mg twice daily resulted in a 77% decrease in gastric acid secretion in 9 patients, while 3 others showed a decrease of 10–13% while 2 exhibited no effect. In addition, the bark extract at the dose of 30–60 mg twice daily for 10 weeks in 6 patients displayed significant reduction of duodenal ulcers ( 30 ). A larger study in 80 patients with type 2 diabetes mellitus described how the leaves and twigs of Neem have the potential to significantly reduce glycosylated hemoglobin (HbA1c) levels, insulin resistance (IR)/fasting blood sugar (FBS) and systemic inflammation ( 31 ). In this study, subjects received capsules of either 125, 250 or 500 mg of Neem [aqueous extract of Azadirachta indica leaves (AIE) and twigs] or placebo twice daily for 12 weeks. At all doses, Neem not only significantly reduced postprandial blood sugar (PPBS) level, HbA1c, FBS and IR but also improved endothelial function, reduced oxidative stress and systemic inflammation when compared to the placebo. The bioactives in these capsules were found to be flavonoids and myo-inositol monophosphate was found to be the predominant bioactive. Neem leaves, seed oil and the bark have also been used against malaria in India, Nigeria, and some other parts of Asia ( 32 - 39 ). The larvicidal properties of Neem seed oil (0.03% azadirachtin) and Neem leaf slurry (over heated Neem leaves dried and minced, extracted using water and water/acetonitrile) was reported to be successful in controlling malaria ( 36 , 38 - 41 ). The Neem seed oil/leaf slurry has been shown to induce sterility in insects by interrupting sperm production in males and hormone control of oogenesis thereby exerting a cytotoxic effect on both follicular cells and oocytes of the malaria vector. To our knowledge, no clinical studies have formally been conducted to evaluate the effects of Neem in cancer patients, however, pre-clinical studies support the usage of Neem and its various components in the treatment of cancer. We present the following article in accordance with the Narrative Review reporting checklist (available at https://atm.amegroups.com/article/view/10.21037/atm-22-94/rc ).

We performed a systematic literature search for all relevant articles in English language from the PubMed, InCommon and Google, limiting the publication date from 1980 to April, 2022. The following key words “Neem”, “Cancer”, “Prostate Cancer” and related terms ( Table 1 ) were used for the literature search. The search was performed at the same time by multiple researchers, and disagreements were resolved through discussions with each other on regular basis for consensus.

Active components of Neem and dose forms

Chemical composition of neem.

Neem is a complex mix of various chemical constituents. Hossain et al. ( 42 ) have shown that the primary constituents of crude Neem leaf extract (NLE) include hydrocarbons, phenolic compounds, terpenoids, alkaloids, and glycosides [2-ethylhexyl tetradecyl est (13.70%), methyl petroselinate (11.23%), eicosane, 7-hexyl (10.01%), heptacosane (8.10%), hexadecamethylcyclo-octasiloxane (7.46%), octacosane (7.09%), heptacosane, 7-hexyl (6.77%), butyl palmitate (6.69%), isobutyl stearate (4.25%), nonadecane (3.75%), (2E)-3,7,11,15-tetramethyl-2-hexadecen-1-ol (2.99%), 2,6,10,14-tetramethylheptadecane (2.68%), phytol (2.61%), methyl isoheptadecanoate (2.19%), and gamma-elemene (1.05%)]. Multiple studies have shown that terpenoids (including limonoids) are primarily responsible for Neem’s biological activities ( Table 2 ). Chemical characterization of Neem extracts via LC-MS by Santos et al. ( 92 ) demonstrated the following terpenoids in Neem extracts; 2,3-Dihydronimbolide (22.8%), Nimbolide + 3-Deacetylsalannin (19.7%), Nimbandiol (12.8%), Nimonol (10.1%), 6-Deacetylnimbinene (9.3%), 6-Deacetylnimbin (8.4%), Gedunin (4.8%), Nimbanal (4.4%), Salannin (3.9%), Rutin (3.6%). It is noteworthy that four different extraction solvents were used in their study and while the percentage of each compound obtained in each extraction fraction was similar, their concentration varied depending on the polarity and capacity of different solvent used for the extraction.

EAD, epoxyazadiradione.

Active compounds of Neem

Multiple medically active compounds including terpenoids and steroids have been isolated from Neem. The most highly studied compounds are azadirachtin, nimbolinin, nimbin, nimbidin, and nimbidol, however, multiple other bioactive components have also been identified ( Table 2 ) ( 18 , 29 ). The well documented flavonoid, quercetin, has also been identified in NLE ( 48 ).

The limonoids, azadirachtin and nimbolide were shown to inhibit the DMBA-induced buccal pouch carcinomas through inhibition of tumor invasion, suppression of procarcinogen activation and oxidative DNA damage in addition to upregulation of antioxidant and carcinogen detoxification enzymes ( 93 , 94 ). These limonoids also displayed inhibition of HeLa cervical cancer cell growth via a cell cycle arrest mechanism in the G0/G1 phase. The study described an upregulation of p21, p53, reactive oxygen species (ROS), Bax, survivin and a downregulation of cyclin B and D, Bcl-2, PCNA and NF-κB upon treatment with these limonoids ( 95 ).

Azadiradione extracted from the seeds of Neem were found to be effective in ameliorating symptoms in mammalian and fly models of neurodegenerative diseases making it a potential candidate for consideration against neurodegenerative diseases ( 43 ). Additionally, Azadiradione and Gedunin were found to bind and inactivate human pancreatic α-amylase (a well-known anti-diabetic target) and thus are considered as lead drug candidates to control post-prandial hyperglycemia ( 44 ). Azadiramide B, isolated from the extracts of Bacillus subtilis -fermented Neem seeds was shown to selectively inhibit the growth of MDA-MB-231 a triple-negative breast cancer (TNBC) cell line with an IC 50 value of 15.73±6.07 µM ( 28 ). Azadirone was found to sensitize cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a ROS-ERK-CHOP-mediated up-regulation of death receptor DR5 and DR4 signaling in addition to a decrease in cell survival proteins, and an increase in proapoptotic proteins ( 45 ).

Another Neem derivative, Catechin, was found to be one of the best phytocompounds against dental plaque forming bacteria and displayed promise as a drug for treating biofilm related acute infections ( 46 , 47 ). Epicatechin was reported as a potent antibacterial agent in addition to its antioxidative activity ( 46 , 48 ). Epoxyazadiradione (EAD) extracted from the Neem seeds was found to induce mitochondrial apoptosis and inhibited NF-κB nuclear translocation in human cervical cancer cells ( 50 ). The study demonstrated that EAD is a potent and safe chemotherapeutic agent. Another study reported that EAD suppressed breast tumor growth via mitochondrial depolarization in addition to caspase-dependent apoptosis by attenuating PI3K/Akt-mediated AP-1 activation ( 49 ).

Neem is known for its antibacterial and antifungal activity that is mainly attributed to its bioactive compounds such as nimbidin, nimbolide, mahmoodin, margolone, margolonone, and isomargolonone ( 52 ). Nimbidin is a mixture of tetranor-triterpenes extracted from Neem oil. It has been reported as a potent anti-inflammatory and anti-arthritic agent. Recent studies reported that oral administration of 5–25 mg/kg nimbidin to rats for 3 consecutive days significantly inhibited the migration of macrophages to their peritoneal cavities in response to inflammatory stimuli. Thus, nimbidin could be useful for treating inflammation/inflammatory diseases ( 96 ). Nimbidin was also shown to exhibit significant gastric anti-secretory activity in pylorus ligated rats and cats. At the dose of 40 mg/kg (i.v.) to perfused rats, nimbidin suppressed carbachol stimulated gastric acid output ( 97 ). Recent studies have shown that nimbin, an active compound extracted from Neem leaf, has anti-viral effect against dengue virus. Interestingly nimbin was reported to be effective against the envelope protein of different types of the dengue virus ( 72 ). A very recent study used molecular docking to show that nimbin exhibits highest interaction with spike glycoprotein of SARS-CoV-2 with a MolDock score of 148.621 kcal/moL and ACE2 receptor with MolDock score—140.108 kcal/moL. This suggests that NLE may be useful as a therapeutic and/or prophylactic agent for SARS-CoV-2 ( 98 ).

Nimbolide, extracted from the Neem leaves, is known for its pathogenicity against various cancers by inhibiting cell proliferation, causing apoptosis, and impairing invasion and metastasis ( 99 ). Nimbolide was reported to inhibit breast cancer cell proliferation by disrupting RNF114-substrate recognition that results in the inhibition of ubiquitination and degradation of tumor suppressors such as Cyclin Dependent Kinase Inhibitor 1A (p21) ( 100 ). Several studies demonstrated potential of nimbolide as an antibacterial agent for the treatment of infections caused by multidrug-resistant strains in addition to its antimalarial potential ( 16 , 36 , 101 ). Nimonol is known for its antifungal activity against Fusarium oxysporum, Rhizoctonia solani, Alternaria solani and Sclerotinia sclerotiorum ( 86 - 88 ). Nimbinene was reported to have anticancer effect on breast cancer by inducing ROS generation resulting in mitochondria-mediated apoptosis ( 89 , 90 ). Nimbinene was also reported to have anti-insecticidal activity ( 91 ). Given the large number of compounds with medicinal properties extracted from this one plant, it is no wonder that a number of patents on various parts of the tree and its extracts (USA, Japan, Australia, India) have been awarded, and are now being commercialized for various treatments ( 102 ). Generally Neem is accepted in the ayurvedic medical tradition as a therapy for various diseases as there are still many hurdles that limits large-scale use of Neem. One of the biggest hurdles in the commercialization of Neem is the lack of industrial interest, mainly due to the difficulty in patenting natural products, in addition to lack of enough scientific evidence or documents to support the benefits of these natural substances. These limitations must be overcome by proper scientific evidence and documentations so that the full potential of Neem can be explored. Unfortunately, due to these limitations many of these products have not been tried in PCa or other diseases.

Neem has various components which contribute to the many dosage forms of Azadirachta indica . The most common used parts of Neem are the leaves and seeds. Components of Neem are often extracted with water or ethanol ( 10 , 103 ). The extract can stay in an aqueous fluid or be further dried to make a powder ( 29 , 104 ). Seed oil can be extracted with ethanol and supercritical carbon dioxide (CO 2 ), among other solutions. Neem plant extracts (NPEs) have many indications. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles composed from Neem leaf-extracted nimbolide have anticancer effects. The PLGA polymer surface can be modified by conjugating polyethylene glycol with receptor binding ligands for targeted delivery of nimbolide in cancer treatments ( 105 ).

Other extracts from Neem plant, such as Neem gum collected from incised bark of Azadirachta indica trees, has an abundance of functional groups which make it efficient for drug delivery applications. Bioadhesive buccal tablets, made from Neem gum, containing nicorandil were studied for its potential to increase contact between drug and absorbing surface, to prevent first pass effect, lengthen half-life and ultimately reduce frequency of nicorandil administration during treatment of hypertension and angina pectoris ( 106 ). Neem gum has also been used to make hydrogel for drug delivery of anticancer drug methotrexate (MTX) under different pH conditions. Neem gum-based hydrogel was determined to be a good carrier for MTX as the gel protects the drug from hostile environmental conditions, releases the drug in optimal quantities, therefore reducing the toxic side effects ( 107 ). Carbon dots, derived from Neem gum have biolinkers attached on their surface and stable green fluorescence which make them suitable for drug delivery system and/or biosensors ( 108 ).

Natural NPE also has the ability to reduce ions and has been used to reduce silver ions for hydrogel nanocomposite with mechanical toughness, large swelling and deswelling ability and electrical conductivity. Synthetic reducing agents limit potential silver hydrogel nanocomposite biomedical applications due to toxicity from harsh synthesis conditions ( 109 ). Reducing and stabilizing properties of aqueous NLE from Neem mistletoe was also tested for its ability to fabricate silver nanoparticles (AgNPs). Neem reduced AgNPs were found to be cytotoxic against human breast carcinoma cell lines and therefore a promising candidate for cancer therapy ( 110 ). In addition to plant extracts, Neem fungal endophyte, Fusarium oxysporum , has also been studied for its possible anticancer application. Gold nanoparticles derived from Fusarium oxysporum is anti-proliferative towards breast cancer, Burkitt lymphoma and human peripheral blood mononuclear cells, while safe toward normal human cells ( 111 ). Neem nanoemulsions (NE) have also been utilized for drug delivery purposes ( 112 ). NE from Neem seed oil has been used as drug delivery dosage form for poorly aqueous soluble drugs. Neem oil anti-oxidant properties were maintained in NE dosage form ( 113 ).

Use of Neem and its components for inhibition of PCa cells and tumor growth

Using natural compounds in pca.

A growing number of natural compounds have been tested in PCa, with varying results. Docetaxel, an FDA approved chemotherapeutic that is now standard-of-care for PCa, is a derivative of paclitaxel, which is derived from the bark of the Pacific yew tree ( Taxus brevifolia ) ( 114 ). However, other common foods and dietary supplements (e.g., green tea; pomegranate; lycopene; soy; mistletoe; vitamins C, D, and E; selenium; resveratrol) which are used by patients as treatments for cancer ( 115 ), did not receive FDA approval. This is due to various reasons such as variations in content of the trial compound and lack of financial incentives for funders to conduct phase III trials. The success of paclitaxel suggests that natural compounds for specific diseases is moved forward when clearly defined and active molecules from the natural product are used rather than whole extracts. The fact that so many of the Neem ingredients have been patented is therefore encouraging.

To date, only a handful of Neem products have been tested in PCa. Interest in Neem as a treatment for PCa stems from the fact that in India, where Neem is widely available, Neem oil is used as a male contraceptive ( 116 ). Later, a study in 2006 demonstrated that Neem ethanol extract induced apoptosis in PC-3 cells, which are of PCa origin ( 10 ). Since PC-3 cells do not express the AR, a key regulator of PCa in most cases, the scientific community remained unconvinced until in 2011 it was demonstrated that similar extracts also affected LNCaP cells, and C4-2B tumor xenografts—both of which express a mutant AR(T877A) ( 11 , 12 ). In 2014 Nimbolide, the active ingredient of Neem, was shown to have effects in PC-3 cells similar to that of the ethanol extract ( 9 ), while other studies suggested that the active ingredients of the Neem extract affecting LNCaP xenografts included nimbandiol, nimbolide, 2',3'-dihydronimbolide, and 28-deoxonimbolide ( 13 ). Importantly, these ingredients appeared to inhibit both the AR and the PI3K/Akt pathway that is important in the growth of PCa cells ( 9 , 11 , 13 ).

Inhibition of the AR pathway

The AR signaling pathway is important for normal functioning of prostate cells. Binding of androgen ligands such as testosterone and dihydrotestosterone (DHT) to cytoplasmic AR causes a conformational change in the receptor that enables nuclear translocation of AR and subsequent activation of the AR gene that governs growth and viability of prostate cells ( 117 ). Aberrant AR signaling has been implicated in primary PCa and in castration-resistant prostate cancer (CRPC) ( 118 ). Multiple pre-clinical reports have documented the efficacy of Neem extracts in PCa models ( 8 , 12 , 13 ). In 2014, Wu et al. ( 13 ) evaluated the use of supercritical extract of Neem leaves (SENL) as a treatment for in vitro and in vivo models of PCa. Supercritical extract refers to the use of supercritical fluid grade CO 2 —that is, CO 2 that is held at or above its critical temperature (31.1 °C) and critical pressure (72.9 atm/7.39 MPa), for extracting components from Neem. The AR is a steroid receptor that is highly expressed, not only in hormone sensitive prostate cancer (HSPC), but also in CRPC. The study showed that both the AR-positive HSPC cell line LNCaP and the AR-null CRPC PC-3 cell lines responded to SENL in vitro . SENL suppressed integrin β1, calreticulin and focal adhesion kinase activation ( Figure 2 ). In addition, the report suggests suppression of cell growth, induction of apoptosis and significant reduction in DHT-induced AR and prostate-specific antigen (PSA) levels. DHT is a powerful AR ligand that binds to the receptor and enables its localization to the nucleus, where the AR binds to target DNA and promotes transcription of target genes including PSA that is used as a biomarker to track AR activity in the prostate. Also, in mice bearing LNCaP xenograft tumors, oral administration of SENL was found to reduce xenograft tumor volume ( 13 ). These results support a tumor suppressive action of Neem in AR associated PCa. It may be noted that ethanolic extract of Neem leaves (EENL) was found to decrease the relative expression of AR after 48 hours of treatment at 1.0 µg/mL in MCF-7 and MDA-MB-231 breast cancer cell lines ( 119 ). Thus, the effect of Neem on the AR pathway was not confined to PCa alone.

The effect of Neem on different pathways. The figure is created using BioRender ( https://biorender.com/ ). AR, androgen receptor; DHT, dihydrotestosterone; ROS, reactive oxygen species.

Inhibition of the PI3K/Akt pathway

The PI3K/Akt signaling pathway is a key transduction cascade involved in promoting survival and growth of malignant cancer cells. PI3Ks are a family of related intracellular enzymes that phosphorylate a hydroxyl group on the inositol ring of a phosphatidylinositol ( 120 ). The PI3K family is divided into four different classes: Class IA PI3Ks are composed of a heterodimer between a p110 catalytic subunit and a p85 regulatory subunit ( 120 ) while class IB PI3Ks are heterodimers of a p110 catalytic subunit and a p101 regulatory subunit. Class II comprises of three catalytic isoforms, but, unlike Classes I and III, has no regulatory proteins. Class III is primarily involved in the trafficking of proteins and vesicles and has both regulatory and catalytic subunits. The Class IA catalytic subunit p110α is the best understood and is transcribed by the oncogene PIK3CA . It catalyzes the conversion of phosphatidylinositol 4,5-bisphosphate [PI( 4 , 5 )P 2 ] into phosphatidylinositol 3,4,5-trisphosphate [PI( 3 , 4 , 5 )P 3 ], an event that is reversed by the tumor suppressor PTEN, a phosphatase. [PI( 3 , 4 , 5 )P 3 ] phosphorylates a number of downstream targets including phosphoinositide-dependent kinase-1 (PDK1) ( 121 ), which in turn phosphorylates key survival kinases such as Akt1 at Thr308 ( 122 ). Akt has a number of cellular functions that promote the progression of PCa to CRPC ( 123 ).

Owing to its strong association with cancer development and progression, multiple studies have aimed to target the PI3K/Akt pathway for anti-cancer therapy ( 9 , 11 ). Inhibiting the PI3K/Akt pathways leads to apoptosis via key players like Bad, caspase 3 and NF-Kβ ( 124 ). In 2014, Raja Singh et al. ( 9 ) demonstrated that nimbolide can cause apoptosis by inhibiting the PI3K/Akt pathway in PC-3 cells. Their results showed that nimbolide induced apoptosis by activating DNA fragmentation in PC-3 cells. In addition, nimbolide treatment increased the expression of pro-apoptotic genes such as Fas ligand, FADDR, Bax, Bad and IGF binding protein 3, while decreasing the expression of PI3K, Akt, IGF1 and IGF1R. Nimbolide also increased protein expression of caspases 8, 3, 10, 9, Bax and cytochrome c while it decreased the expression of XIAP, Bcl2, cleaved PARP, p-Akt and IGF1R ( Figure 2 ). Similarly, Gunadharini et al. ( 11 ) observed an induction of apoptosis and inhibition of cell proliferation through the inhibition of the PI3K/Akt pathway in both LNCaP and PC-3 cell lines. Ethanolic Neem caused 50% inhibition at a dose of 100 µg/mL in both PC-3 and LNCaP cells and had similar effects on the PI3K/Akt pathway. Decrease in p-Akt by Neem caused an increase in the protein level of Bad and p21 while it decreased cyclin D1 levels supporting the notion that Neem affected both cell proliferation and survival via the PI3K/Akt pathway.

The presence of phytochemicals such as nimbolide (a major limonoid) In the Neem extracts may confer major advantages to the use of Neem extracts in comparison to single-molecule targeting pathway inhibitors since nimbolide has been shown to target multiple proteins and non-coding RNAs involved in the PI3K/Akt pathway. Sophia et al. ( 125 ) showed that in SCC131 and SCC4 oral cancer cells, nimbolide induces apoptosis in cancer cells by modulating the phosphorylation of proteins Akt and GSK-3β and ncRNAs miR-26 and HOTAIR causing the inactivation of the PI3K/Akt/GSK3 signalling pathway. Nimbolide induced targeting of the complex interaction of molecules involved in the PI3K/Akt pathway may therefore be more beneficial as a cancer therapeutic than inhibitors.

Inhibition of alternative pathways driving PCa progression and resistance to therapy

Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine that activates the cytoplasmic transcription factor NF-κB through a proteasome-mediated degradation of I-κB (inhibitor of NF-κB). Activated NF-κB then undergoes nuclear translocation and activates cell survival pathways ( 126 ). Singh et al. ( 7 ) showed that nimbolide suppressed expression of the TNF-α/TNFR1 signaling molecules TNF-α, SODD, Grb2, SOS mRNA which regulate NF-κB and MAPK pathways and thereby inhibited the survival and proliferation of PCa cells ( Figure 2 ). Zhang et al. ( 8 ) also demonstrated that treatment of DU145 and LNCaP cells with nimbolide significantly inhibited cell viability, induced apoptosis, and suppressed tumor cell invasion and migration in vitro . Their subsequent in vivo studies using the transgenic adenocarcinoma of mouse prostate (TRAMP) model demonstrated that nimbolide treatment suppressed tumor growth and decreased metastasis without significant side effects. The tumor suppressive effects were attributed to STAT3 inhibition caused by increased production of ROS due to an imbalance of the glutathione redox system (GSH/GSSG). The authors showed that nimbolide downregulates the activation of STAT3 transcription factor through the induction of oxidative stress ( Figure 2 ). They found significant GSH reduction and GSSG increase in nimbolide treated cells compared to untreated cells. Similarly, Kumar et al. ( 10 ), in 2006, studied the effect of ethanolic Neem extract on the PCa cell line PC-3 in vitro . Using immunoblotting they showed a decreased level of anti-apoptotic protein Bcl-2 and an increased level of Bax protein with a subsequent increase in apoptosis with an increasing dosage of Neem extract.

Mahapatra et al. ( 12 ), in 2011, studied the effect of ethanolic Neem extract in vitro and in vivo models of PCa using C4-2B and PC-3M-luc2 PCa cells through qPCR and immunoblotting. They reported that ethanolic Neem extract caused an upregulation of cell death and drug metabolism genes, a down regulation of cell cycle, DNA replication, recombination, and repair genes in vitro , and tumor growth inhibition in C4-2B and PC-3M-luc2 PCa xenograft models in nude mice. Srivastava et al. ( 14 ) in 2012 used Neem oil containing multiple limonoids on LNCaP cells and reported that Neem induced caspase dependent and apoptosis inducing factor (AIF) mediated apoptosis and autophagy in PCa cells. They demonstrated that Neem limonoids caused release of mitochondrial cytochrome c and AIF resulting in caspase dependent and caspase independent cell death, respectively. They also reported p53 independent induction of autophagy in cells treated with limonoids.

Tables 3,4 ​ 3,4 outline various studies that shows in vivo and in vitro anticancer effects of Neem on PCa.

PCa, prostate cancer; ENLE, ethanolic Neem leaf extract; SENL, supercritical extract of Neem leaves.

PCa, prostate cancer; SENL, supercritical extract of Neem leaves.

Impact of Neem and Neem-derived compounds on some common cancer-related physiological processes. The anti-cancer activity of Neem has been studied using cell line and animal models which are representative of multiple types of cancers, for example skin, cervical, ovarian, breast, colon lung, stomach, liver, bladder cancers and Ehrlich’s carcinoma (EC) as well as PCa ( Table 5 ). The data from these studies demonstrate that Neem and its derivatives can inhibit the common physiological processes which drive cancer incidence and progression and can thereby be used to help further inform Neem usage for PCa.

PCa, prostate cancer; NLE, Neem leaf extract; ROS, reactive oxygen species; EC, Ehrlich’s carcinoma.

Promotion of apoptosis

Killing cancer cells is the goal of most chemotherapy regimens ( 135 , 136 ). Neem and its components have been shown to promote apoptosis in several cancer types ( 19 , 20 , 24 , 77 , 78 , 125 , 137 - 139 ). For example, treatment of HeLa cells with ENLE resulted in cell death associated morphological changes at 175 µg/mL over time (up to 48 hours) ( 140 ). Ethanolic solution of Neem seed oil (contains azadirachtin and nimbin) was found to be cytotoxic to MDA-MB-231 and MCF-7 breast cancer cells at an IC 50 of 20 and 10 µL/mL solution concentration, respectively ( 24 ). Efficacy has also been observed in vivo ; an animal model study of stomach cancer demonstrated that Neem leaf extract (AAILE) could reduce tumor size ( 141 ). Several studies indicate apoptosis occurs due to activation of the intrinsic pathway of apoptosis, and that components of the NF-kB pathway also play a role. For example, treatment of hepatocarcinoma cell lines with Neem decreased Bcl-2 expression levels and increased caspase-3 and Bax expression (components of the intrinsic pathway of apoptosis) and that this occurred due to decreased expression of p50 and p65 (key components of the NF-kB pathway) ( 78 ). Nimbolide has also been shown to promote cancer cell apoptosis in neuroblastoma and colon cancer through reducing Bcl-2 levels while increasing Bax levels and caspase levels ( 133 , 142 , 143 ). When used in combination with standard of care cytotoxic chemotherapy, Neem and Neem-based products can further increase drug-mediated cancer cell apoptosis. For example, treatment of HeLa cells (derived from a cervical cancer patient) with a combination of cisplatin and ENLE resulted in a 50% increase it cytotoxicity when compared with treatment with Neem or cisplatin as single agents ( 140 ). Nimbolide induced apoptosis in PC-3 cells by activating DNA fragmentation, and increased levels of the Fas ligand, FADDR, Bax, Bad and IGF binding protein 3, while decreasing PI3K, Akt, IGF1 and IGF1R. Nimbolide also increased the expression of caspases 8, 3, 10, 9, and cytochrome c and decreased the expression of XIAP, Bcl2, cleaved PARP and p-Akt ( 9 ). ENLE was also shown to induce DNA fragmentation in PC-3 cells ( 10 ), and induced apoptosis in both LNCaP and PC-3 ( 11 ). Another study showed that ENLE-suppression of C4-2B and PC-3M-luc2 tumor growth is associated with the formation of hyalinized fibrous tumor tissue and the induction of cell death by apoptosis, as well as an increase in the protein expression levels of HMOX1, AKR1C2, AKR1C3, and AKR1B10 ( 12 ). Thus there is significant evidence that Neem extracts can induce apoptosis in PCa cells.

Inhibition of cell proliferation

Many cancer drugs work by inhibiting cancer cell proliferation ( 144 ). Neem and its components have been shown to inhibit the proliferation of several types of cancer cells. For example, azadirachtin can inhibit cervical cancer cells (HeLa) by decreasing levels of cyclin B and cyclin D1 and thereby causing cell cycle arrest at the G0/G1 phase ( 145 ). Nimbolide has been demonstrated to reduce proliferation of bladder cancer cells at an IC 50 of 3 µM with cell cycle arrest in the G2/M phase ( 81 ), and in oral squamous cell carcinoma can reduce cell proliferation in a dose-dependent manner ( 127 ). In swiss albino mice, NLE was used as prophylactic treatment for EC ( 134 , 146 ). In this study, a significant increase in antibody production against B16 melanoma antigen was detected in mice treated with Neem leaf preparation (NLP) once weekly for 4 weeks. An increase in number of splenic T lymphocytes (CD4 + and CD8 + ) and NK cells were also recorded in treated mice. Nimbolide treatment also suppressed expression of TNF-α, SODD, Grb2, SOS mRNA and modulated TNF-α/TNFR1 regulated NF-κB and MAPK signaling molecules in PC-3 cells ( 7 ). This inhibited PCa cell survival and proliferation via NF-κB and MAPK pathways. Nimbolide acts as a potent anti-cancer agent by inhibiting cell proliferation via PI3K/Akt pathway in PC-3 cells ( 9 ). Treatment of C4-2B and PC-3M-luc2 cells with ENLE also inhibited cell proliferation ( 12 ). Similar effects were also seen in LNCaP and PC-3 cells ( 11 ). These evidences point to anti-proliferative effects of Neem derivatives that can be used in preventing PCa proliferation.

Angiogenesis

Angiogenesis promotes cancer metastasis and as such is a key target of several cancer drugs, for example bevacizumab and thalidomide ( 147 ). Angiogenesis also plays a key role in driving PCa progression ( 148 ). Neem and its components have been shown to inhibit angiogenesis through suppressing levels of vascular endothelial growth factor (VEGF) and thereby inhibiting proliferation, migration, and invasion of human umbilical vein endothelial cells (HUVEC) ( 90 ). An in vivo study by Gupta et al. ( 149 ) showed that the Neem component nimbolide (at 5 and 20 mg/kg b.w., i.p.) significantly reduced the growth of colorectal cancer xenografts. They found a significant downregulation in the expression of NF-κB regulated tumorigenic proteins including VEGF, the growth factor which drives angiogenesis. Another in vivo study in DMBA-induced hamster buccal pouch (HBP) carcinogenesis model demonstrated inhibition of angiogenesis by NLE when administered at 10 mg/kg body weight ( 150 ). After analyzing the mechanism of chemo-prevention they found multitargeted mode of action including angiogenesis and multiple polar phytochemicals responsible for the action ( 150 ). A similar study also using the DMBA-induced HBP carcinogenesis model compared the chemopreventive potential of the Neem limonoids azadirachtin and nimbolide. They found that nimbolide was a more potent antioxidant and chemopreventive agent as compared to azadirachtin and results in multitargeted prevention and treatment of cancer including inhibition of tumor invasion and angiogenesis ( 94 ). While no published studies focused on the role of Neem in preventing angiogenesis in PCa, the above reports point to the possibility of using Neem extracts and derivatives in an anti-angiogenic role.

Inhibition of inflammation

Inflammation has been shown to contribute to the incidence and progression of several cancer types, including PCa ( 151 ). Inflammation primarily occurs through activation of the NF-kB signaling pathway ( 152 - 154 ). While anti-inflammatory drugs such as prednisone and dexamethasone are often co-administered with chemotherapy to help reduce inflammation and other chemotherapy-related side effects ( 155 ), they are not currently used as individual agents for PCa chemoprevention or treatment, however, several pre-clinical studies are on-going to test their effects ( 156 ). Preclinical studies in other cancer types indicate that Neem can inhibit inflammation through abrogation of the synthesis and/or activation of cytokines, transcription factors, enzymes, and receptors which drive NF-kB signaling pathway activation ( 26 , 48 ). For example, in chronic myeloid leukemia (CML) K562 and Jurkat cells, it was shown that quercetin, a component of NLE (100 µM), could inhibit TNF-α induced NF-kB signaling ( 48 ). In the same study, it was found that this was due to the ability of NLE and quercetin to reduce the catalytic activity of IKKβ. Multiple studies also point to a role for Neem and its derivatives in preventing NF-kB signaling in PCa ( 7 ). Thus, PCa inflammation can be suppressed by Neem as well.

Impact of combining Neem with standard of care treatments for cancer

Cancer is a complex disease which needs amalgamation of multiple regimens to enhance efficacy, particularly for late-stage disease. For example, a common treatment regimen for CRPC are the androgen synthesis inhibitor Abiraterone acetate plus prednisone, the AR inhibitors enzalutamide, apalutamide and darolutamide, the chemotherapeutic agents docetaxel and cabazitaxel, and others such as the radiotherapeutic radium-223 and the immunotherapeutic sipuleucel-T ( 157 ). Several studies have reported that Neem extracts can induce chemo-sensitization of tumor cells in addition to reducing the adverse effects and toxicity of chemotherapeutic drugs. For example, combination therapy of Neem-derived Gedunin and cisplatin was evaluated on SKOV3, OVCAR4, and OVCAR8 ovarian cancer cell lines proliferation. Their results showed about 50% decrease in proliferation of cancer cells compared to the cells treated with only cisplatin ( 158 ). Another study showed the synergistic growth inhibition of breast and cervical cells via combinations of ethanolic Neem leaf extract (ENLE) with cisplatin as compared to the individual drugs, combination index <1 ( 140 ). The adriamycin (ADR) resistance in multidrug-resistant MCF-7 human breast cancer cell line is associated with the presence of high-level expression of P-glycoprotein. Quercetin, a Neem-extracted flavonoid was shown to reduce the expression of P-glycoprotein in MCF-7 ADR-resistant cells and thus proved to show additive effect on ADR therapy for breast cancer in vitro study ( 159 ). Ghosh et al. ( 160 ) showed in both in vitro and in vivo conditions that NLE is an effective tool to reduce CYP-induced hematological complications such as the occurrence of leukopenia and neutropenia that are found to be a life-threatening complication of chemotherapy. They found that treatment with NLE alleviates CYP-caused leukopenia and neutropenia in both normal mice and the tumor bearing mice ( 160 ). Another study showed that NLE has significant effect in prevention of leukocyte apoptosis that may happen by treatment with cisplatin plus 5-fluorouracil (5-FU) in swiss mice ( 161 ). In addition, they report that the efficacy of NLE is comparable to granulocyte colony stimulating factor (GCSF) in its ability to protect against leukocyte apoptosis induced by chemo agents and that it would be a better choice of treatment because GCSF is found to be tumor promoting and expensive. Cisplatin is one of the most valuable and potent chemotherapeutic drug used for the treatment of broad spectrum of malignancies such as testicular, head and neck, ovarian, cervical, and NSC-lung carcinoma. However, its clinical dose-limiting side effect is nephrotoxicity. Abdel Moneim et al. ( 162 ) showed that methanolic NLE can attenuate cisplatin-induced nephrotoxicity. In their study, they investigated the effects of methanolic NLE (500 mg/kg bwt) given by gastric gavage on cisplatin induced toxicity of kidneys in rats. The injuries of the renal tissue (as histopathological damages and increased serum uric acid, urea, and creatinine) by cisplatin were rescued by oral administration of methanolic NLE for 5 days. In addition, the other major side effect of cisplatin, hepatotoxicity, could also be prevented by administration of Neem leaf supplements ( 137 ). A significant decrease of elevated serum aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bilirubin, urea, uric acid, and creatinine was observed by before or after administration of Neem supplement. Another study reported that nimbolide, a triterpenoid isolated from Neem, can enhance the sensitization of tumor cells to chemotherapeutic agents by inhibiting the activation of NF-κB ( 163 ). While Neem has not been shown to be effective against docetaxel, it has been found to be effective in paclitaxel resistant colon cancer and liver cancer cells ( 164 ). It remains to be seen whether Neem can be effective in docetaxel resistant PCa cells as well.

While medicinal plants, including Neem, have been used for several millennia for diverse purposes in the life of mankind particularly as medicines for the treatment of various diseases, it is well known that some of them can have serious toxicities at higher doses. A major concern is that extraction methods can change the concentration of specific compounds and that the concentration of these compounds in the final extract is often unknown. Toxicities have been reported for Neem and Neem products. For example, excessively high doses of Neem oil has been demonstrated to cause poisoning in children in the form of hepatic toxicity, encephalopathy, metabolic acidosis, vomiting and at lower levels in adults ( 165 ). A case study on a patient who had accidently consumed 20 mL of Neem Oil reported that the patient suffered seizures, vomiting and encephalopathy. The potential for toxicity of Neem extracts has been investigated in several animal models. When mice were treated with Neem in an aqueous extract form it was found to have an LD 50 value of 13 g/kg (which is quite high), similar values were obtained when using methanolic extract form in rats ( 26 ). However, other groups showed that the aqueous extract of Neem leaf is not toxic to rats and they reported LD 50 as >2.5 g/kg body weight ( 166 ). The latter group demonstrated in their toxicity studies that no mortality observed with 2.5 g/kg dose of AIE in mice and no significant alterations in body or tissues weight, food and water intake, hematological profile and various liver and kidney function in rats when treated for 28 days with 1 g/kg dose of AIE. In addition, Raizada et al. ( 167 ) found that azadirachtin from Neem when administered orally to rats of both sexes at doses of 500, 1,000 and 1,500 mg/kg/day for 90 days did not produce any signs of toxicity, mortality, changes in tissue weight, pathology and serum and blood parameters. Toxicities may also result from the route of administration. For example, nimbolide and nimbic acid, when given intravenously (i.v.) or intraperitoneally (i.p.) led to causalities in both rats and rabbits with 24 hours LD 50 values of 14 and 24 mL/kg, respectively whereas it wasn’t toxic when given via intragastric (i.g.) route ( 168 ).

The combined data indicate that caution should still be taken when consuming Neem and Neem products even though Neem-based products have been consumed for several millennia and the controlled consumption of Neem products can be considered as safe.

Other uses of Neem

Azadirachta indica , which can be found in abundance in the southeast Asian tropics, demonstrates ability to act as efficacious dosage forms for pesticidal agents as well as cytotoxic agents. In a study, Neem powder was revealed to have similar biopesticidal effects on larvae as aqueous NLE. However in equal concentrations, powdered Neem appeared to act faster on mosquitoes than its aqueous counterpart ( 104 ). In comparing NLE and Neem oil as fungicidal agents, Neem oil seemed to be more effective at suppressing fungal growth than NLE ( 169 ). Many studies find NLE to be efficacious biocidal agents. Methanolic extract of Neem leaves were synthesized into anti-bacterial microspheres and incorporated into a topical gel for the treatment of bacterial infection. The methanolic extract of Neem leaves overcomes poisonous effects of its synthetic gel counterpart ( 170 ). ENLE was used to form ethosome for dermal delivery of a biocidal fungicidal agent called luliconazole. The dosage form was successful for sustained release, targeted delivery, and increased drug permeability through lipid vesicle which all aided to enhance the bioavailability of luliconazole ( 171 ). Neem leaf powder was combined with alginate to create beads for fungicide thiram delivery and found to potentiate pesticide contents due to inherent pesticidal activity with less toxic effects ( 172 ). Neem leaf powder has also been used to make activated charcoal and shown to adsorb heavy metals (Pb, Cu, Cd, Zn, Ni, Cr) in a spontaneous, endothermic and favorable manner ( 173 ).

In addition to the above plant extracts, seed oil from the Azadirachta indica have also been utilized for its biocidal effects. Neem oil is notable for its biologically active compound azadirachtin which has been promoted as a low cost, eco-friendly and easy to handle insecticide ( 174 ). Zein nanoparticles, a precipitated dosage form of Neem oil, employ an environmentally friendly antisolvent. The nanocarrier allows lower doses and numbers of applications of the pesticide in agriculture ( 175 ). NE were compared to non-formulated Neem oil. NE was found to increase mortality of tested species Sitophilus oryzae and Tribolium castaneum with less toxicity than synthetic pesticide ( 176 ). Larvicidal properties of Neem oil were studied as urea NE which demonstrated to be an environmentally benign efficacious form of A. aegypti and C. tritaeniorhynchus mosquito control. Neem oil has also been studied for its ability to disrupt bacterial cell membrane of Vibrio vulnificus. The antibacterial NE was found to be nontoxic to human lymphocytes at lower concentrations, but possibly toxic to human lymphocytes at higher concentrations with depletion of catalase, SOD and GSH ( 177 ).

Conclusions and future perspective

Neem and Neem-based products can clearly inhibit the processes which drive PCa incidence, progression, and resistance to chemotherapy in pre-clinical settings, and do so by inhibiting the pathways known to mediate these processes including the AR pathway, PI3K/Akt pathway, and intrinsic pathway of apoptosis amongst others. This, combined with the favorable safety profile of Neem, indicates that clinical studies of Neem for the treatment of PCa are warranted. Which Neem derivative should be used for clinical studies is a major consideration as pre-clinical studies have not directly compared efficacy or mechanism of action and there are likely to be differences between them. With this in mind, consideration should be given to matching known effects of each Neem product with PCa disease stage and/or knowledge of which pathway is driving patient disease progression or resistance to therapy. Further investigation of Neem and Neem products for treatment of PCa is supported by their relatively low cost and low toxicity levels, as long as used at reasonable (physiological) doses, and used in reasonable routes of administration. It may be kept in mind, that taxols, when first isolated from the bark of the Pacific yew tree, was considered to be toxic, but then went on to create therapeutic history by being one of the most widely used chemotherapeutic drugs available.

Supplementary

Acknowledgments.

Some figures were generated using BioRender ( https://biorender.com/ ).

Funding: Funding for this project was provided by California Northstate University College of Pharmacy and University of California, Davis.

Ethical Statement : The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Reporting Checklist : The authors have completed the Narrative Review reporting checklist. Available at https://atm.amegroups.com/article/view/10.21037/atm-22-94/rc

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-94/coif ). The authors have no conflicts of interest to declare.

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to  upgrade your browser .

Enter the email address you signed up with and we'll email you a reset link.

• We're Hiring!
• Help Center

Azadirachta indica (neem): a plant of multiple biological and pharmacological activities

2009, Phytochemistry Reviews

Related Papers

Gustav Komlaga , Kate Ofori

Economic Botany

Memory Elvin-Lewis

European Journal of Medicinal Plants

Saganuwan Saganuwan

Abdurahman H Nour

African Journal of Traditional, Complementary and Alternative Medicines

Amom Tor-anyiin

African Journal of Traditional, Complementary and …

Gustav Komlaga

Journal of Bacteriology & Parasitology

Cletus Anes

GSC Biological and Pharmaceutical Sciences

Chukwunonso A N T H O N Y Nsude

Neem Azadirachta indica is a useful traditional medicinal plant growing in Nigeria, India, and America. The phytochemicals and the biopesticidal components present were ascertained. The results showed that saponins, steroids and terpenes were mostly present, while tannins and glycosides were moderately present, and alkaloids, flavonoids, phenols and oxalic acid were least present. The presence of these phytochemical could account for the therapeutic uses of neem.

The Pharma Innovation Journal

Ragini Gothalwal

Azadirachta indica is a very useful traditional medicinal plant in the sub-continent and each part of the tree has some medicinal properties. The plant is native to Asia, but has now naturalized in West Africa and is widely cultivated in Nigeria as an ornamental as well as medicinal plant. Fresh leaves of the plant were collected, dried, homogenized and extracted using 95% Ethanol, Methanol and Acetone. Phytochemical analysis gave positive results for steroids, triterpinoids, reducing sugars, alkaloids, phenolic compounds, flavonoids and tannins. This study aimed at screening the active components and the antibacterial effects of the Ethanol, Methanol and Acetone. Leaf extract of Azadiracta indica contains pharmacologically active constituents that may be responsible for its activity against P. falcifarum in vitro and P. vivax in vivo model. Therefore, the use of Neem plant in our community for treating diverse medical ailments especially infectious diseases is highly justified.

Journal of Bioanalysis &amp; Biomedicine

Mohaiminul Likhan

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

RELATED PAPERS

Pharmaceutical Biology

Edith Ajaiyeoba

European Journal of Biomedical AND Pharmaceutical sciences

sharang Bali

Gabino Garrido

AARF Publications Journals

Medicinal and Aromatic Plant Science and Biotechnology

Global Science Books

Texila International Journal , Niharika Anand

Journal of Ethnopharmacology

Laura Pontiggia

The Journal of Phytopharmacology

DANIEL GAKUYA

Journal of Pharmaceutical Negative Results

Dr. Sharad Visht

Mushfique Ravish

International Journal of Research

ali abba gana benisheikh

Acta fytotechnica et zootechnica

Unchalee Sanguanpong

Ethnobotany Research and Applications

Abdulmalik Adamu

Comfort Yusuf

EGBUNA CHUKWUEBUKA , C. Egbuna , Ifemeje Jonathan

Paula Melariri

MOSES OWOLABI

International Journal

Lateef Oseni

Oghale Ovuakporie-Uvo

Advance Pharmaceutical Journal

Pradeep Vikram

Arpita Padhy

Catherine Fennell

Journal of Diseases and Medicinal Plants

Abdulrasheed Haruna Haruna

Emmanuel Ayodeji Ayeni

RELATED TOPICS

•   We're Hiring!
•   Help Center
• Find new research papers in:
• Health Sciences
• Earth Sciences
• Cognitive Science
• Mathematics
• Computer Science
• Academia ©2024

• [email protected]
• +971 507 888 742

Journal of Biological Sciences

• Vol 14 (2), 2014

Review Article

Neem ( azadirachta indica ) and its potential for safeguarding health of animals and humans: a review.

Received: October 22, 2013;   Accepted: November 08, 2013;   Published: January 11, 2014

How to cite this article

Introduction.

CONCLUSION AND FUTURE PERSPECTIVES

• Abdel-Ghaffar, F., S. Al-Quraishy, K.A.S. Al-Rasheid and H. Mehlhorn, 2012. Efficacy of a single treatment of head lice with a neem seed extract: An in vivo and in vitro study on nits and motile stages. Parasitol. Res., 110: 277-280. CrossRef PubMed
• Akihisa, T., T. Noto, A. Takahashi, Y. Fujit and N. Banno et al ., 2009. Melanogenesis inhibitory, anti-inflammatory and chemopreventive effects of limonoids from the seeds of Azadirachta indicia A. Juss. (neem). J. Oleo Sci., 58: 581-594. CrossRef PubMed
• Akihisa, T., A. Takahashi, T. Kikuchi, M. Takagi and K. Watanabe et al ., 2011. The melanogenesis-inhibitory, anti-inflammatory and chemopreventive effects of limonoids in n-hexane extract of Azadirachta indica A. Juss. (neem) seeds. J. Oleo Sci., 60: 53-59. CrossRef PubMed
• Al-Quraishy, S., F. Abdel-Ghaffar, K.A. Al-Rasheid, J. Mehlhorn and H. Mehlhorn, 2012. Effects of a neem seed extract (MiteStop ® ) on mallophages (featherlings) of chicken: In vivo and in vitro studies. Parasitol. Res., 110: 617-622. CrossRef
• Al-Quraishy, S., F. Abdel-Ghaffar, K.A. Al-Rasheid, J. Mehlhorn and H. Mehlhorn, 2012. Observations on effects of a neem seed extract (MiteStop ® ) on biting lice (mallophages) and bloodsucking insects parasitizing horses. Parasitol. Res., 110: 335-339. CrossRef
• Al-Samarrai, G., H. Singh and M. Syarhabil, 2012. Evaluating eco-friendly botanicals (natural plant extracts) as alternatives to synthetic fungicides. Ann. Agric. Environ. Med., 19: 673-676. PubMed
• Anjali, C.H., Y. Sharma, A. Mukherjee and N. Chandrasekaran, 2012. Neem oil ( Azadirachta indica ) nanoemulsion-a potent larvicidal agent against Culex quinquefasciatus . Pest Manage. Sci., 68: 158-163. CrossRef Direct Link
• Ansari, M.A. and R.K. Razdan, 1996. Operational feasibility of malaria control by burning neem oil in kerosene lamp in Beel Akbarpur village, District Ghaziabad, India. Indian J. Malariol., 33: 81-87. PubMed
• Anyaehie, U.B., 2009. Medicinal properties of fractionated acetone/water neem ( Azadirachta indica ) leaf extract from nigeria: A review. Niger. J. Physiol. Sci., 24: 157-159. PubMed Direct Link
• Aravindan, S., M. Natarajan, T.S. Herman, V. Awasthi and N. Aravindan, 2013. Molecular basis of hypoxic breast cancer cell radio-sensitization: Phytochemicals converge on radiation induced Rel signaling. Radiat. Oncol., Vol. 8. CrossRef
• Mukherjee, A.K., R. Doley and D. Saikia, 2008. Isolation of a snake venom phospholipase A 2 (PLA 2 ) inhibitor (AIPLAI) from leaves of Azadirachta indica (Neem): Mechanism of PLA 2 inhibition by AIPLAI in vitro condition. Toxicon, 51: 1548-1553. CrossRef PubMed
• Badam, L., S.P. Joshi and S.S. Bedekar, 1999. In vitro antiviral activity of neem ( Azadirachta indica , A. Juss) leaf extract against group B Coxsackie viruses . J. Commun. Dis, 31: 79-90. PubMed
• Balappanavar, A.Y., V. Sardana and M. Singh, 2013. Comparison of the effectiveness of 0.5% tea, 2% neem and 0.2% chlorhexidine mouthwashes on oral health: A randomized control trial. Indian J. Dent. Res., 24: 26-34. PubMed
• Bandyopadhyay, U., K. Biswas, A. Sengupta, P. Moitra and P. Dutta et al ., 2004. Clinical studies on the effect of neem ( Azadirachta indica ) bark extract on gastric secretion and gastroduodenal ulcer. Life Sci., 75: 2867-2878. CrossRef Direct Link
• Banken, J.A.O. and J.D. Stark, 1997. Stage and age influence on the susceptibility of Coccinella septempunctata (Coleoptera: Coccinellidae) after direct exposure to Neemix, a neem insecticide. J. Econ. Entomol., 90: 1102-1105. Direct Link
• Baral, R., I. Mandal and U. Chattopadhyay, 2005. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine. Int. Immunopharmacol., 5: 1343-1352. Direct Link
• Bedri, S., E.A. Khalil, S.A. Khalid, M.A. Alzohairy and A. Mohieldein et al ., 2013. Azadirachta indica ethanolic extract protects neurons from apoptosis and mitigates brain swelling in experimental cerebral malaria. Malaria J., Vol. 12. CrossRef
• Beuth, J., H. Schneider and H.L. Ko, 2006. Enhancement of immune responses to neem leaf extract ( Azadirachta indica ) correlates with antineoplastic activity in BALB/c-mice. In Vivo , 20: 247-251. PubMed Direct Link
• Bhowmik, D., Chiranjib, J. Yadav, K.K. Tripathi and K.P.S. Kumar, 2010. Herbal remedies of Azadirachta indica and its medicinal application. J. Chem. Pharm. Res., 2: 62-72. Direct Link
• Biswas, K., I. Chattopadhyay, R.K. Banerjee and U. Bandyopadhyay, 2002. Biological activities and medicinal properties of neem ( Azadirachta indica ). Curr. Sci., 82: 1336-1345. Direct Link
• Biu, A.A., S.D. Yusufu and J.S. Rabo, 2009. Phytochemical screening of Azadirachta indica (Meliaceae) in Maiduguri, Nigeria. Biosci. Res. Commun., 21: 281-283.
• Bonsu, F.R.K., J.K. Kagya-Agyemang, W.K.J. Kwenin and H.K. Zanu, 2012. Medicinal response of broiler chickens to diets containing neem ( Azadirachta indica ) leaf meal, haematology and meat sensory analysis. World Applied Sci. J., 19: 800-805. Direct Link
• Chagas, A.C.S., L.S. Vieira, A.R. Freitas, M.R.A. Araujo, J.A. Araujo-Filho, W.R. Araguao and A.M.C. Navarro, 2008. Anthelmintic efficacy of neem ( Azadirachta indica A. Juss) and the homeopathic product Fator Vermes ® in Morada Nova sheep. Vet. Parasitol., 151: 68-73. CrossRef Direct Link
• Chakraborty, K., A. Bose, S. Pal, K. Sarkar and S. Goswami et al ., 2008. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance. Int. Immunopharmacol., 8: 330-340. CrossRef Direct Link
• Chary, P., 2011. A comprehensive study on characterization of elite Neem chemotypes through mycofloral, tissue-cultural, ecomorphological and molecular analyses using azadirachtin-A as a biomarker. Physiol. Mol. Biol. Plants, 17: 49-64. CrossRef PubMed
• Chatterjee, R., O. Singh, L. Pachuau, S.P. Malik and M. Paul et al ., 2010. Identification of a sulfonoquinovosyldiacylglyceride from Azadirachta indica and studies on its cytotoxic activity and DNA binding properties. Bioorg. Med. Chem. Lett., 20: 6699-6702. CrossRef PubMed
• Chattopadhyay, R.R., R.N. Chattopadhyay and S.K. Maitra, 1993. Possible mechanism of anti-inflammatory activity of Azadirachta indica leaf extract. Indian J. Pharmacol., 25: 99-100.
• Chauhan, R.S., 2010. Nutrition, immunity and livestock health. Indian Cow: Scient. Econ. J., 7: 2-13. Direct Link
• Chava, V.R., S.M. Manjunath, A.V. Rajanikanth and N. Sridevi, 2012. The efficacy of neem extract on four microorganisms responsible for causing dental caries viz Streptococcus mutans , Streptococcus salivarius , Streptococcus mitis and Streptococcus sanguis : An in vitro study. J. Contemp. Dental Pract., 13: 769-772. PubMed
• Chopra, I.C., K.C. Gupta and B.N. Nair, 1952. Biological activities and medicinal properties of neem ( Azadirachta indica ). Indian J. Med. Res., 40: 511-515.
• Dasgupta, T., S. Banerjee, P.K. Yadava and A.R. Rao, 2004. Chemopreventive potential of Azadirachta indica (neem) leaf extract in murine carcinogenesis model systems. J. Ethnopharmacol., 92: 23-36. CrossRef PubMed
• Del Serrone, P. and M. Nicoletti, 2013. Antimicrobial activity of a neem cake extract in a broth model meat system. Int. J. Environ. Res. Public Health, 10: 3282-3295. CrossRef
• Dhaliwal, P.K., J.K. Roop and S.S. Guraya, 1998. Antifertility Activity of Neem-Seed Oil in Cyclic Female Rats. In: Ecological Agriculture and Sustainable Development, Dhaliwal, G.S., N.S. Randhawa, A. Arora and A.K. Dhawan (Eds.). Vol. 2, Indian Ecological Society and Centre for Research in Rural and Industrial Development, Chandigarh, India, pp: 340-346.
• Dhaliwal, P.K., J.K. Roo and S.S. Guraya, 1999. Effect of neem-seed oil on the quantitative aspects of follicular development in cyclic female rats. Indian J. Ecol., 26: 162-166.
• Dhama, K., S. Mani, S. Chakraborty, R. Tiwari, A. Kumar, P. Selvaraj and R.B. Rai, 2013. Herbal remedies to combat cancers in humans and animals-A review. Int. J. Curr. Res., 5: 1908-1919. Direct Link
• Dhama, K., S. Chakraborty, Mahima, M.Y. Wani and A.K. Verma et al ., 2013. Novel and emerging therapies safeguarding health of humans and their companion animals: A review. Pak. J. Biol. Sci., 16: 101-111. CrossRef Direct Link
• Dhama, K., S. Chakraborty and R. Tiwari, 2013. Panchgavya therapy (Cowpathy) in safeguarding health of animals and humans: A review. Res. Opin. Anim. Vet. Sci., 3: 170-178. Direct Link
• Dhama, K., S. Chakraborty, M.Y. Wani, R. Tiwari and R. Barathidasan, 2013. Cytokine therapy for combating animal and human diseases-A review. Res. Opin. Anim. Vet. Sci., 3: 195-208. Direct Link
• Dhayanithi, N.B., T.T.A. Kumar and K. Kathiresan, 2010. Effect of neem extract against the bacteria isolated from marine fish. J. Environ. Biol., 31: 409-412.
• Drabu, S., S. Khatr and S. Babu, 2012. Neem: Healer of all ailments. Res. J. Pharm. Biol. Chem. Sci., 3: 120-126.
• Dua, V.K., B.N. Nagpal and V.P. Sharma, 1995. Repellent action of neem cream against mosquitoes. Indian J. Malariol., 32: 47-55. PubMed
• Durrani, F.R., N. Chand, M. Jan, A. Sultan, Z. Durrani and S. Akhtar, 2008. Immunomodulatory and growth promoting effects of neem leaves infusion in broiler chicks. Sarhad J. Agric., 24: 655-659. Direct Link
• Elavarasu, S., P. Abinaya, S. Elanchezhiyan, Thangakumaran, K. Vennila and K.B. Naziya, 2012. Evaluation of anti-plaque microbial activity of Azadirachta indica (neem oil) in vitro : A pilot study. J. Pharm. Bioallied Sci., 4: S394-S396. PubMed
• Tahir, A.I., A.M. Ibrahim, G.M.H. Satti, T.G. Theander, A. Kharazmi and A.S. Khalid, 1998. The potential antileishmanial activity of some Sudanese medicinal plants. Phytother. Res., 12: 576-579. Direct Link
• Elumalai, P., D.N. Gunadharini, K. Senthilkumar, S. Banudevi and R. Arunkumar et al ., 2012. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol. Lett., 215: 131-142. CrossRef PubMed
• Faccin-Galhardi, L.C., K.A. Yamamoto, S. Ray, B. Ray, R.E.C. Linhares and C. Nozawa, 2012. The in vitro antiviral property of Azadirachta indica polysaccharides for poliovirus. J. Ethnopharmacol., 142: 86-90. PubMed
• Farah, M.A., B. Ateeq and W. Ahmad, 2006. Antimutagenic effect of neem leaves extract in freshwater fish, Channa punctatus evaluated by cytogenetic tests. Sci. Total Environ., 364: 200-214. CrossRef PubMed
• Farahna, M., S. Bedri, S. Khalid, M. Idris, C.R. Pillai and E.A. Khalil, 2010. Anti-plasmodial effects of Azadirachta indica in experimental cerebral malaria: Apoptosis of cerebellar Purkinje cells of mice as a marker. N. Am. J. Med. Sci., 2: 518-525. PubMed
• Garboui, S.S., T.G. Jaenson and K. Palsson, 2006. Repellency of MyggA ® Natural spray (para-menthane-3,8-diol) and RB86 (neem oil) against the tick Ixodes ricinus (Acari: Ixodidae) in the field in east-central Sweden. Exp. Applied Acarol., 40: 271-277. CrossRef
• Gbotolorun, S.C., A.A. Osinubi, C.C. Noronha and A.O. Okanlawon, 2008. Antifertility potential of Neem flower extract on adult female Sprague-Dawley rats. Afr. Health Sci., 8: 168-173. Direct Link
• Geraldo, M.R., C.L. da Costa, C.C. Arroteia and C. Kemmelmeier, 2011. The neem [ Azadirachta indica a. juss (meliaceae)] oil reduction in the in vitro production of zearalenone by Fusarium graminearum . Braz. J. Microbiol., 42: 707-710.
• Ghosh, D., A. Bose, E. Haque and R.N. Baral, 2006. Pretreatment with neem ( Azadirachta indica ) leaf preparation in swiss mice diminishes leukopenia and enhances the antitumor activity of cyclophosphamide. Phytother. Res., 20: 814-818. PubMed
• Girish, K. and S.S. Bhat, 2008. Neem-A green treasure. J. Biol., 4: 102-111. Direct Link
• Goswami, S., A. Bose, K. Sarkar, S. Roy, T. Chakraborty, U. Sanyal and R. Baral, 2010. Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions. Vaccine, 28: 1241-1252. CrossRef Direct Link
• Govindachari, T.R., 1992. Chemical and Biological Investigations on Azadirachta indica (the neem tree). Curr. Sci., 63: 117-122. Direct Link
• Habluetzel, A., F. Carnevali, L. Lucantoni, L. Grana and A.R. Attili et al ., 2007. Impact of the botanical insecticide Neem Azal ® on survival and reproduction of the biting louse Damalinia limbata on angora goats. Vet. Parasitol., 144: 328-337. CrossRef Direct Link
• Haque, E., I. Mandal, S. Pal and R. Baral, 2006. Prophylactic dose of neem ( Azadirachta indica ) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory. Immunopharmacol. Immunotoxicol., 28: 33-50. Direct Link
• Harjai, K., A. Bala, R.K. Gupta and R. Sharma, 2013. Leaf extract of Azadirachta indica (neem): A potential antibiofilm agent for Pseudomonas aeruginosa . Pathog. Dis., 69: 62-65. CrossRef Direct Link
• Jacobson, M., 1995. Antifertility Effects and Population Control. In: The Neem Tree, Schummtterer, H. (Ed.). VCH Publication, Hoshenheim, Germany, pp: 526-530.
• Johnson, S., E.D. Morgan and C.N. Peiris, 1996. Development of the major triterpenoids and oil in the fruit and seeds of neem ( Azadirachta indica ). J. Ann. Bot., 78: 383-388. CrossRef Direct Link
• Jothi, D., 2009. Experimental study on antimicrobial activity of cotton fabric treated with aloe gel extract from Aloe vera plant for controlling the Staphylococcus aureus (bacterium). Afr. J. Microbiol. Res., 3: 228-232.
• Juneja, S.C. and R.S. Williams, 1993. Mouse sperm-egg interaction in vitro in the presence of neem oil. Life Sci., 53: PL279-PL284. CrossRef Direct Link
• Juneja, S.C., T. Pfeifer, R.S. Williams and N. Chegini, 1994. Neem oil inhibits two-cell embryo development and trophectoderm attachment and proliferation in vitro . J. Assist. Rep. Genet., 11: 419-427. PubMed
• Karunamoorthi, K., A. Mulelam and F. Wassie, 2009. Assessment of knowledge and usage custom of traditional insect/mosquito repellent plants in Addis Zemen Town, South Gonder, North Western Ethiopia. J. Ethnopharmacol., 121: 49-53. CrossRef PubMed
• Kavitha, K., R.V. Priyadarsini, P. Anitha, K. Ramalingam and R. Sakthivel et al ., 2012. Nimbolide, a neem limonoid abrogates canonical NF-κB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells. Eur. J. Pharmacol., 681: 6-14. CrossRef Direct Link
• Khan, S., Azizuddin, S.A. Halim, M. Kashif and A. Jabeen et al ., 2013. In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of Dianabol through Azadirachta indica and its molecular docking studies. Chem. Central J., Vol. 7.
• Kudom, A.A., B.A. Mensah and M.A. Botchey, 2011. Aqueous neem extract versus neem powder on Culex quinquefasciatus : Implications for control in anthropogenic habitats. J. Insect Sci., Vol. 11. CrossRef Direct Link
• Kumar, S., R.P. Raman, K. Kumar, P.K. Pandey, N. Kumar, S. Mohanty and A. Kumar, 2012. In vitro and in vivo antiparasitic activity of Azadirachtin against Argulus spp. in Carassius auratus (Linn. 1758). Parasitol. Res., 110: 1795-1800. CrossRef Direct Link
• Kumar, V.S. and V. Navaratnam, 2013. Neem ( Azadirachta indica ): Prehistory to contemporary medicinal uses to humankind. Asian Pac. J. Trop. Biomed., 3: 505-514. CrossRef Direct Link
• Kweka, E.J., F.W. Mosha, A. Lowassa, A.M. Mahande and M.J. Mahande et al ., 2008. Longitudinal evaluation of Ocimum and other plants effects on the feeding behavioral response of mosquitoes (Diptera: Culicidae) in the field in Tanzania. Parasites Vectors, Vol. 1. CrossRef
• Lucantoni, L., F. Giusti, M. Cristofaro, L. Pasqualini, F. Esposito, P. Lupetti and A. Habluetzel, 2006. Effects of a neem extract on blood feeding, oviposition and oocyte ultrastructure in Anopheles stephensi Liston (Diptera: Culicidae). Tissue Cell, 38: 361-371. CrossRef Direct Link
• Lucantoni, L., R.S. Yerbanga, G. Lupidi, L. Pasqualini, F. Esposito and A. Habluetzel, 2010. Transmission blocking activity of a standardized neem ( Azadirachta indica ) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensi . Malaria J., Vol. 9. CrossRef
• Luong, K., F.V. Dunkel, K. Coulibaly and N.E. Beckage, 2012. Potential use of neem leaf slurry as a sustainable dry season management strategy to control the malaria vector Anopheles gambiae (Diptera: Culicidae) in West African villages. J. Med. Entomol., 49: 1361-1369. Direct Link
• Lyons, D.B., B.V. Helson, G.C. Jones and J.W. McFarlane, 1998. Effectiveness of neem-and diflubenzuron-based insecticides for control of the pine false webworm, Acantholyda erythrocephala (L.) (Hymenoptera: Pamphiliidae). Proc. Entomol. Soc. Ontario, 129: 115-126.
• Lyons, D.B., B.V. Helson, G.C. Jones, J.W. McFarlane and T. Scarr, 1996. Systemic activity of neem seed extracts containing azadirachtin in pine foliage for control of the pine false webworm, Acantholyda erythrocephala (Hymenoptera: Pamphiliidae). Proc. Entomol. Soc. Ontario, 127: 45-55.
• Maciel, M.V., S.M. Morais, C.M. Bevilaqua, R.A. Silva and R.S. Barros et al ., 2010. In vitro insecticidal activity of seed neem oil on Lutzomyia longipalpis (Diptera: Psychodidae). Rev. Bras. Parasitol. Vet., 19: 7-11. PubMed
• Mahapatra, S., R.J. Karnes, M.W. Holmes, C.Y.F. Young and J.C. Cheville et al ., 2011. Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer. AAPS J., 13: 365-377. CrossRef PubMed
• Mahima, A. Rahal, R. Deb, S.K. Latheef and H.A. Samad et al ., 2012. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pak. J. Biol. Sci., 15: 754-774. CrossRef Direct Link
• Mahima, A.K. Verma, R. Tiwari, K. Karthik, S. Chakraborty, R. Deb and K. Dhama, 2013. Nutraceuticals from fruits and vegetables at a glance: A review. J. Biol. Sci., 13: 38-47. CrossRef Direct Link
• Mahima, A.M. Ingle, A.K. Verma, R. Tiwari and K. Karthik et al ., 2013. Immunomodulators in day to day life: A review. Pak. J. Biol. Sci., 16: 826-843. CrossRef Direct Link
• Maity, P., K. Biswas, I. Chattopadhyay, R.K. Banerjee and U. Bandyopadhyay, 2009. The use of neem for controlling gastric hyperacidity and ulcer. Phytother. Res., 23: 747-755. CrossRef PubMed
• Mujumdar, A.M., A.S. Upadhye and A.M. Pradhan, 1998. Effect of Azadirachta indica leaf extract on CCl 4 induced hepatic damage in albino rats. Indian J. Pharmaceutical. Sci., 60: 363-367.
• Makeri, H.K., V.A. Maikai and J.A. Nok, 2007. Effect of topical application of neem seed ( Azadiracta indica ) extract on sheep infested with Amblyomma variegatum . Afr. J. Biotechnol., 6: 2324-2327.
• Maragathavalli, S., S. Brindha, N.S. Kaviyarasi, B. Annadurai and S.K. Gangwar, 2012. Antimicrobial activity in leaf extract of neem ( Azadirachta indica Linn.). Int. J. Sci. Nat., 3: 110-113. Direct Link
• Mehlhorn, H., F. Abdel-Ghaffar, K.A. Al-Rasheid, J. Schmidt and M. Semmler, 2011. Ovicidal effects of a neem seed extract preparation on eggs of body and head lice. Parasitol. Res., 109: 1299-1302. CrossRef PubMed
• Mehrotra, S., A.K. Srivastava and S.P. Nandi, 2010. Comparative antimicrobial activities of Neem, Amla, Aloe, Assam tea and Clove extracts against Vibrio cholera , Staphylococcus aureus and Pseudomonas aeruginosa . J. Med. Plants Res., 4: 2473-2478. Direct Link
• Mishra, V., N. Parveenb, K.C. Singhalc, Nizam and U. Khana, 2005. Antifilarial activity of Azadirachta indica on cattle filarial parasite Setaria cervi . Fitoterapia, 76: 54-61. CrossRef Direct Link
• Asif, M., 2012. Antimicrobial potential of Azadirachta indica against pathogenic bacteria and fungi. J. Pharmacog. Phytochem., 1: 78-83. Direct Link
• Mongkholkhajornsilp, D., S. Douglas, P.L. Douglas, A. Elkamel, W. Teppaitoon and S. Pongamphai, 2004. Supercritical CO 2 extraction of nimbin from neem seeds-a modelling study. J. Food Eng., 71: 331-340. CrossRef Direct Link
• Mukherjee, A. and S. Sengupta, 2013. Characterization of nimbidiol as a potent intestinal disaccharidase and glucoamylase inhibitor present in Azadirachta indica (neem) useful for the treatment of diabetes. J. Enzyme Inhib. Med. Chem., 28: 900-910. CrossRef PubMed
• Mulla, M.S. and T. Su, 1999. Activity and biological effects of Neem products against arthropods of medical and veterinary importance. J. Am. Mosq. Control Assoc., 15: 133-152. PubMed Direct Link
• Nataporn, S., C. Tawatchai and H. Wiwut, 2006. Nanoencapsulation of curcumin in biodegradable chitosan via multiple emulsion/solvent evaporation. Proceedings of the 4th Thailand Material Science and Technology Conference, March 31-April 1, 2006, Bangkok, Thailand.
• Natarajan, V., 2002. Azadirachta indica in the treatment of dermatophytosis. J. Ecobiol., 14: 201-204.
• NRC, 1992. Neem: A Tree for Solving Global Problems. National Academy Press, Washington, DC, ISBN: 9780309046862, Pages: 152. Direct Link
• Nisbet, A.J., J.A.T. Woodford, R.H.C. Strang and J.D. Connoly, 1993. Systemic antifeedant effects of azadirachtin on the peach-potato aphid Myzus persicae . Entomol. Exp. Appl., 68: 87-98. CrossRef Direct Link
• Osman, M.Z. and G.R. Port, 1990. Systemic action of neem seed substances against Pieris brassicae . Entomol. Exp. Appl., 54: 297-300. CrossRef
• Othman, F., G. Motalleb, S.L.T. Peng, A. Rahmat, S. Fakurazi and C.P. Pei, 2011. Extract of Azadirachta indica (Neem) leaf induces apoptosis in 4T1 breast cancer BALB/c mice. Cell J., 13: 107-116. Direct Link
• Parekh, J. and S.V. Chanda, 2007. In vitro antimicrobial activity and phytochemical analysis of some Indian medicinal plants. Turk. J. Biol., 31: 53-58. Direct Link
• Parida, M.M., C. Upadhyay, G. Pandya and A.M. Jana, 2002. Inhibitory potential of neem ( Azadirachta indica Juss) leaves on Dengue virus type-2 replication. J. Ethnopharmacol., 79: 273-278. CrossRef PubMed Direct Link
• Paul, R., M. Prasad and N.K. Sah, 2011. Anticancer biology of Azadirachta indica L (neem): A mini review. Cancer Biol. Ther., 12: 467-476. CrossRef PubMed Direct Link
• Prashant, G.M., G.N. Chandu, K.S. Murulikrishna and M.D. Shafiulla, 2007. The effect of mango and neem extract on four organisms causing dental caries: Streptococcus mutans , Streptococcus salivavius , Streptococcus mitis and Streptococcus sanguis : An in vitro study. Indian J. Dent. Res., 18: 148-151. PubMed Direct Link
• Puri, H.S., 1999. Neem: The Divine Tree Azadirachta Indica . Harwood Academic Publishers, Australia, ISBN: 9057023482, Pages: 166.
• Purwar, R. and M. Joshi, 2004. Recent developments in antimicrobial finishing of textiles: A review. AATCC Rev., 4: 22-26.
• Quarles, W., 1994. Neem tree pesticides product ornamental plants. IPM Pract., 16: 1-13.
• Ragasa, C.Y., Z.D. Nacpil, G.M. Natividad, M. Tada, J.C. Coll and J.A. Rideout, 1997. Tetranortriterpenoids from Azadirachta indica . J. Phytochem., 46: 555-558.
• Raghuvanshi, P., R. Bagga, D. Malhotra, S. Gopalan and G.P. Talwar, 2011. Spermicidal and contraceptive properties of Praneem polyherbal pessary. Indian J. Med. Res., 113: 135-141. PubMed
• Rajendran, R., R. Radhai, C. Balakumar, A.M.A. Hasabo, C. Vigneswaran and K. Vaideki, 2012. Synthesis and characterization of neem chitosan nanocomposites for development of antimicrobial cotton textiles. J. Eng. Fibers Fabrics, 7: 136-141. Direct Link
• Rakib, M.A.A. and M.M. Hussain, 2013. Assessment of cytotoxic effect of methanolic crude extracts of Azadirachta indica . Int. J. Pharm. Sci. Res., 4: 1585-1590.
• Rao, D.R., R. Reuben, M.S. Venugopal, B.A. Nagasampagi and H. Schmutterer, 1992. Evaluation of neem, Azadirachta indica , with and without water management, for the control of culicine mosquito larvae in rice-fields. Med. Vet. Entomol., 6: 318-324.
• Ray, A., B.D. Banerjee and P. Sen, 1996. Modulation of humoral and cell-mediated immune responses by Azadirachta indica (Neem) in mice. Indian J. Exp. Biol., 34: 698-701. PubMed Direct Link
• Renu, S., N.K. Rakha, G. Sandeep and S.K. Mishra, 2003. Effect of Neem ( Azadirachta indica ) leaf extract administration on immune responses of broiler chickens. J. Immunol. Immunopathol., 5: 47-50. Direct Link
• Rosaline, H., D. Kandaswamy, D. Gogulnath and M. Rubin, 2013. Influence of various herbal irrigants as a final rinse on the adherence of Enterococcus faecalis by fluorescence confocal laser scanning microscope. J. Conserv. Dent., 16: 352-355. CrossRef PubMed Direct Link
• Sadekar, R.D., A.Y. Kolte, B.S. Barmase and V.F. Desai, 1998. Immunopotentiating effects of Azadirachta indica (Neem) dry leaves powder in broilers, naturally infected with IBD virus. Indian J. Exp. Biol., 36: 1151-1153. PubMed Direct Link
• SaiRam, M., G. Ilavazhagan, S.K. Sharma, S.A. Dhanraj and B. Suresh et al ., 2000. Anti-microbial activity of a new vaginal contraceptive NIM-76 from neem oil ( Azadirachta indica ). J. Ethnophamacol., 71: 377-382. PubMed Direct Link
• Sarkar, K., A. Bose, S. Laskar, S.K. Choudhuri, S. Dey, P.K. Roychowdhury and R. Baral, 2007. Antibody response against neem leaf preparation recognizes carcinoembryonic antigen. Int. Immunopharmacol., 7: 306-312. CrossRef PubMed Direct Link
• Sarkar, R.K., P. De and P.D. Chauhan, 2003. Bacteria resist finish on cotton fabric using natural herbal extracts. Indian J. Fibre Textile Res., 28: 322-331.
• Sarmiento, W.C., C.C. Maramba and M.L.M. Gonzales, 2011. An in-vitro study on the antibacterial effect of neem ( Azadirachta indica ) leaf extract on methicillin-sensitive and Methicillin-resistant Staphylococcus aureus . PIDSP J., 12: 40-45. Direct Link
• Schmutterer, H., 1990. Properties and potential of natural pesticides from the neem tree, Azadirachta indica . Annu. Rev. Entomol., 35: 271-297. CrossRef Direct Link
• Seddiek, S.A., H.F. Khater, M.M. El-Shorbagy and A.M. Ali, 2013. The acaricidal efficacy of aqueous neem extract and ivermectin against Sarcoptes scabiei var. Cuniculi in experimentally infested rabbits. Parasitol. Res., 112: 2319-2330. CrossRef PubMed
• Pankaj, S., T. Lokeshwar, B. Mukesh and B. Vishnu, 2011. Review on neem ( Azadirachta indica ): Thousand problems one solution. Int. Res. J. Pharm., 2: 97-102. Direct Link
• Shokeen, P., M. Bala and V. Tandon, 2009. Evaluation of the activity of 16 medicinal plants against Neisseria gonorrhoeae . Int. J. Antimicrob. Agents, 33: 86-91. Direct Link
• Srivastava, P., N. Yadav, R. Lella, A. Schneider and A. Jones et al ., 2012. Neem oil limonoids induces p53-independent apoptosis and autophagy. Carcinogenesis, 33: 2199-2207. PubMed
• Stark, J.D. and J.F. Walter, 1995. Neem oil and neem oil components affect the efficacy of commercial neem insecticides. J. Agric. Food Chem., 43: 507-512. CrossRef
• Subapriya, R. and S. Nagini, 2005. Medicinal properties of neem leaves: A review. Curr. Med. Chem.-Anticancer Agents, 5: 149-156. CrossRef PubMed Direct Link
• Subramanian, M.S. and K.K. Lakshmanan, 1996. Azadirachta indica A. Juss. Stem Bark as Antileprosy Source. In: Neem and Enviroment, Singh, R.P., M.S. Chari, A.K. Raheja and W. Kraus (Eds.). Vol. 2, Oxford & IBH Publishing Co., New Delhi, India, pp: 1143-1150.
• Taha, M.M.E., S.I.A. Wahab, F. Othman, P. Hanachi, A.B. Abdul and A.S. Al-Zubairi, 2009. In vivo Anti-tumor effects of Azadirachta indica in rat liver cancer. Res. J. Biol. Sci., 4: 48-53. Direct Link
• Talpur, A.D. and M. Ikhwanuddin, 2013. Azadirachta indica (neem) leaf dietary effects on the immunity response and disease resistance of Asian seabass, Lates calcarifer challenged with Vibrio harveyi . Fish Shellfish Immunol., 34: 254-264. CrossRef PubMed Direct Link
• Tavares, W.S., M.A. Costa, I. Cruz, R.D. Silveira, J.E. Serrao and J.C. Zanuncio, 2010. Selective effects of natural and synthetic insecticides on mortality of Spodoptera frugiperda (Lepidoptera: Noctuidae) and its predator Eriopis connexa (Coleoptera: Coccinellidae). J. Environ. Sci. Health B, 45: 557-561. PubMed
• Thas, J.J., 2008. Siddha medicine: Background and principles and the application for skin diseases. Clin. Dermatol., 26: 62-78. CrossRef
• Thatte, U.M. and S.A. Dahanukar, 1997. The Rasayana Concept: Clues from Immunomodulatory Therapy. In: Immunomodulation, Upadhayaya, S.N. (Ed.). Narosa Publishing House, New Delhi, India, pp: 141-148.
• Tiwari, R., S. Chakraborty, K. Dhama, S. Rajagunalan and S.V. Singh, 2013. Antibiotic resistance-an emerging health problem: Causes, worries, challenges and solutions: A review. Int. J. Curr. Res., 5: 1880-1892. Direct Link
• Tiwari, R., S. Chakraborty, K. Dhama, M.Y. Wani, A. Kumar and S. Kapoor, 2013. Wonder world of phages: Potential biocontrol agents safeguarding biosphere and health of animals and humans-current scenario and perspectives. Pak. J. Biol. Sci., (In Press). Direct Link
• Tiwari, V., N.A. Darmani, B.Y. Yue and D. Shukla, 2010. In vitro antiviral activity of neem ( Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection. Phytother. Res., 24: 1132-1140. CrossRef PubMed
• Tripathi, A., N. Chandrasekaran, A.M. Raichur and A. Mukherjee, 2009. Antibacterial applications of silver nanoparticles synthesized by aqueous extract of Azadirachta indica (Neem) leaves. J. Biomed. Nanotechnol., 5: 93-98. PubMed Direct Link
• Udeinya, I.J., A.U. Mbah, C.P. Chijioke and E.N. Shu, 2004. An antimalarial extract from neem leaves is antiretroviral. Trans. R. Soc. Trop. Med. Hyg., 98: 435-437. PubMed
• Udeinya, I.J., E.N. Shu, I. Quakyi and F.O. Ajayi, 2008. An antimalarial neem leaf extract has both schizonticidal and gametocytocidal activities. Am. J. Ther., 15: 108-110. PubMed
• UNEP, 2012. Neem: The UN's tree of the 21st century. United Nations Environment Programme, Nairobi, Kenya.
• Upadhyay, S.N., S. Dhawan, S. Garg and G.P. Talwar, 1992. Immunomodulatory effects of neem ( Azadirachta indica ) oil. Int. J. Immunopharmacol., 14: 1187-1193. PubMed
• Vanna, G.S., 1976. Miracles of Neem Tree. Rosayan Phamacy, New Delhi, India.
• Pankajalakshmi, V.V. and V.V. Taralakshmi, 1994. Antidermatophytic activity of neem ( Azadirachta indica ) leaves in vitro . Indian J. Pharmacol., 26: 141-143. Direct Link
• Verkerk, R.H.J. and D.J. Wright, 1993. Biological activity of Neem seed kernel extracts and synthetic azadirachtin against larvae of Plutella xylostella L. Pesticide Sci., 37: 83-91. CrossRef Direct Link
• Vinoth, B., R. Manivasagaperumal and M. Rajaravindran, 2012. Phytochemical analysis and antibacterial activity of Azadirachta indica A juss. Int. J. Res. Plant Sci., 2: 50-55. Direct Link
• Vinothkumar, T.S., M.I. Rubin, L. Balaji and D. Kandaswamy, 2013. In vitro evaluation of five different herbal extracts as an antimicrobial endodontic irrigant using real time quantitative polymerase chain reaction. J. Conserv. Dentistry, 16: 167-170. CrossRef PubMed Direct Link
• Waheed, A., G.A. Miana and S.I. Ahmad, 2006. Clinical investigation of hypoglycemic effect of seeds of Azadirachta-inidca in type-2 (NIDDM) diabetes mellitus. Pak. J. Pharm. Sci., 19: 322-325. PubMed Direct Link
• Walldorf, V., H. Mehlhorn, S. Al-Quraishy, K.A. Al-Rasheid, F. Abdel-Ghaffar and J. Mehlhorn, 2012. Treatment with a neem seed extract (MiteStop ® ) of beetle larvae parasitizing the plumage of poultry. Parasitol. Res., 110: 623-627. Direct Link
• Wanner, K.W., B.V. Helson and B.C. Kostyk, 1997. Foliar and systemic applications of neem seed extract for control of spruce budworm, Choristoneura fumiferana (Clem.) (Lepidoptera:Tortricidae), infesting black and white spruce seed orchards. Can. Entomol., 129: 645-655. Direct Link
• WHO, 2008. World Malaria Report 2008. WHO, Geneva, Swirzerland, ISBN: 9241563699, Pages: 190.
• Xu, J., X. Song, Z.Q. Yin, A.C. Cheng and R.Y. Jia et al ., 2012. Antiviral activity and mode of action of extracts from neem seed kernel against duck plague virus in vitro 1. Poult. Sci., 91: 2802-2807. Direct Link
• Yanes, A., H.J. Finol and M. Hasegawa, 2004. Effects of Azadirachta indica and Melia azedarach (Meliaceae) extracts from leaves on Trypanosoma cruzi growth and ultrastructure. J. Submicroscopic Cytol. Pathol., 36: 149-154. PubMed
• Tiwari, R., S. Chakraborty and K. Dhama, 2013. Miracle of herbs in antibiotic resistant wounds and skin infections: Treasure of nature-a review/perspective. Pharm. Sci. Monitor, 4: 214-248. Direct Link
• Van Der Nat, J.M., J. Klerx, H. Van Dijk, K.T. De Silva and R.P. Labadie, 1987. Immunomodulatory activity of an aqueous extract of Azadirachta indica stem bark. J. Ethnopharmacol., 19: 125-131. CrossRef PubMed Direct Link

Related Articles

Leave a Comment

Your email address will not be published. Required fields are marked *

Information

• Author Services

Initiatives

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .

Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.

Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.

Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.

Original Submission Date Received: .

• Active Journals
• Find a Journal
• Proceedings Series
• For Authors
• For Reviewers
• For Editors
• For Librarians
• For Publishers
• For Societies
• For Conference Organizers
• Open Access Policy
• Institutional Open Access Program
• Special Issues Guidelines
• Editorial Process
• Research and Publication Ethics
• Article Processing Charges
• Testimonials
• Preprints.org
• SciProfiles
• Encyclopedia

Article Menu

• Subscribe SciFeed
• Recommended Articles
• Author Biographies
• Google Scholar
• on Google Scholar
• Table of Contents

Find support for a specific problem in the support section of our website.

Please let us know what you think of our products and services.

Visit our dedicated information section to learn more about MDPI.

JSmol Viewer

Test procedures and mechanical properties of three-dimensional printable concrete enclosing different mix proportions: a review and bibliometric analysis.

1. Introduction

2. mix proportions, 3. fresh and hardened properties, 3.1. fresh properties, 3.2. hardened properties, 4. testing procedures, 4.1. extrudability test, 4.2. yield stress, 4.3. buildability test, 4.4. robustness test, 4.5. flowability test, 4.6. compressive strength test, 4.7. porosity evaluation, 4.8. bond strength assessment, 4.9. flexural strength evaluation, 5. bibliometric analysis, 5.1. methodology, 5.2. literature samples, 5.3. research keywords, 5.4. sources of documents, 5.5. authors with highest citation, 5.6. impact of research institutions, 5.7. countries, 6. economic considerations and environmental sustainability, 7. conclusions, 8. recommendations and future vision, author contributions, data availability statement, acknowledgments, conflicts of interest.

• Martinez, S.; Balaguer, C.; Jardon, A.; Navarro, J.; Gimenez, A.; Barcena, C. Robotized lean assembly in the building industry. In Proceedings of the 25th International Symposium on Automation and Robotics in Construction, Vilnius, Lithuania, 26–29 June 2008. [ Google Scholar ]
• Kazemian, A.; Yuan, X.; Cochran, E.; Khoshnevis, B. Cementitious materials for construction-scale 3D printing: Laboratory testing of fresh printing mixture. Constr. Build. Mater. 2017 , 145 , 639–647. [ Google Scholar ] [ CrossRef ]
• Wohlers, T. Rapid prototyping & tooling state of the industry: 1998 worldwide progress report. Mater. Technol. 1998 , 13 , 174–176. [ Google Scholar ]
• Ahmed, G.H. A review of “3D concrete printing”: Materials and process characterization, economic considerations and environmental sustainability. J. Build. Eng. 2023 , 66 , 105863. [ Google Scholar ] [ CrossRef ]
• Nerella, V.N.; Krause, M.; Mechtcherine, V. Direct printing test for buildability of 3D-printable concrete considering economic viability. Autom. Constr. 2020 , 109 , 102986. [ Google Scholar ] [ CrossRef ]
• Wang, J.; Liu, Z.; Hou, J.; Ge, M. Research Progress and Trend Analysis of Concrete 3D Printing Technology Based on CiteSpace. Buildings 2024 , 14 , 989. [ Google Scholar ] [ CrossRef ]
• Khoshnevis, B.; Hwang, D.; Yao, K.-T.; Yeh, Z. Mega-scale fabrication by contour crafting. Int. J. Ind. Syst. Eng. 2006 , 1 , 301–320. [ Google Scholar ] [ CrossRef ]
• Khoshnevis, B.; Dutton, R. Innovative rapid prototyping process makes large sized, smooth surfaced complex shapes in a wide variety of materials. Mater. Technol. 1998 , 13 , 53–56. [ Google Scholar ] [ CrossRef ]
• Khoshnevis, B. Automated construction by contour crafting—Related robotics and information technologies. Autom. Constr. 2004 , 13 , 5–19. [ Google Scholar ] [ CrossRef ]
• Tay, Y.W.D.; Panda, B.; Paul, S.C.; Noor Mohamed, N.A.; Tan, M.J.; Leong, K.F. 3D printing trends in building and construction industry: A review. Virtual Phys. Prototyp. 2017 , 12 , 261–276. [ Google Scholar ] [ CrossRef ]
• Wolfs, R.; Bos, F.; Salet, T. Early age mechanical behaviour of 3D printed concrete: Numerical modelling and experimental testing. Cem. Concr. Res. 2018 , 106 , 103–116. [ Google Scholar ] [ CrossRef ]
• De Schutter, G.; Lesage, K.; Mechtcherine, V.; Nerella, V.N.; Habert, G.; Agusti-Juan, I. Vision of 3D printing with concrete—Technical, economic and environmental potentials. Cem. Concr. Res. 2018 , 112 , 25–36. [ Google Scholar ] [ CrossRef ]
• Wangler, T.; Lloret, E.; Reiter, L.; Hack, N.; Gramazio, F.; Kohler, M.; Bernhard, M.; Dillenburger, B.; Buchli, J.; Roussel, N. Digital concrete: Opportunities and challenges. RILEM Tech. Lett. 2016 , 1 , 67–75. [ Google Scholar ] [ CrossRef ]
• Bos, F.P.; Ahmed, Z.Y.; Wolfs, R.J.; Salet, T.A. 3D printing concrete with reinforcement. In High Tech Concrete: Where Technology and Engineering Meet ; Springer: Berlin/Heidelberg, Germany, 2018; pp. 2484–2493. [ Google Scholar ]
• Labonnote, N.; Rønnquist, A.; Manum, B.; Rüther, P. Additive construction: State-of-the-art, challenges and opportunities. Autom. Constr. 2016 , 72 , 347–366. [ Google Scholar ] [ CrossRef ]
• Tu, H.; Wei, Z.; Alireza, B.; Nabil, B.K.; Ayaz, A.; Yasin, O.Ö. Recent advancements and future trends in 3D printing concrete using waste materials. Dev. Built Environ. 2023 , 16 , 100187. [ Google Scholar ] [ CrossRef ]
• Rahul, A.; Santhanam, M.; Meena, H.; Ghani, Z. 3D printable concrete: Mixture design and test methods. Cem. Concr. Compos. 2019 , 97 , 13–23. [ Google Scholar ] [ CrossRef ]
• Rahul, A.; Santhanam, M.; Meena, H.; Ghani, Z. Mechanical characterization of 3D printable concrete. Constr. Build. Mater. 2019 , 227 , 116710. [ Google Scholar ] [ CrossRef ]
• Cheng, H.; Aleksandra, R.; Michael, H.; Liu, F.; Wang, J. Modeling concrete deposition via 3D printing using reproducing kernel particle method. Cem. Concr. Res. 2024 , 181 , 107526. [ Google Scholar ] [ CrossRef ]
• Mueller, B. Additive manufacturing technologies–Rapid prototyping to direct digital manufacturing. Assem. Autom. 2012 , 32 , 1–12. [ Google Scholar ] [ CrossRef ]
• Tay, Y.W.D.; Qian, Y.; Tan, M.J. Printability region for 3D concrete printing using slump and slump flow test. Compos. Part B Eng. 2019 , 174 , 106968. [ Google Scholar ] [ CrossRef ]
• Parmigiani, S.; Devid, F.; Sandro, M.; Giuseppe, A.F.; Luciana, R. 3D-printed multi-functional foamed concrete building components: Material properties, component design, and 3D printing application. Dev. Built Environ. 2024 , 19 , 100483. [ Google Scholar ] [ CrossRef ]
• Hasani, A.; Sattar, D. Transforming construction? Evaluation of the state of structural 3D concrete printing in research and practice. Constr. Build. Mater. 2024 , 438 , 137027. [ Google Scholar ] [ CrossRef ]
• Lim, S.; Buswell, R.A.; Le, T.T.; Austin, S.A.; Gibb, A.G.; Thorpe, T. Developments in construction-scale additive manufacturing processes. Autom. Constr. 2012 , 21 , 262–268. [ Google Scholar ] [ CrossRef ]
• Ramakrishnan, S.; Kirubajiny, P.; Viktor, M.; Jay, S. Printhead mixing of geopolymer and OPC slurries for hybrid alkali-activated cement in 3D concrete printing. Constr. Build. Mater. 2024 , 430 , 136439. [ Google Scholar ] [ CrossRef ]
• Perkins, I.; Skitmore, M. Three-dimensional printing in the construction industry: A review. Int. J. Constr. Manag. 2015 , 15 , 1–9. [ Google Scholar ] [ CrossRef ]
• Buswell, R.A.; Soar, R.C.; Gibb, A.G.; Thorpe, A. Freeform construction: Mega-scale rapid manufacturing for construction. Autom. Constr. 2007 , 16 , 224–231. [ Google Scholar ] [ CrossRef ]
• Gosselin, C.; Duballet, R.; Roux, P.; Gaudillière, N.; Dirrenberger, J.; Morel, P. Large-scale 3D printing of ultra-high performance concrete–a new processing route for architects and builders. Mater. Des. 2016 , 100 , 102–109. [ Google Scholar ] [ CrossRef ]
• Lloret, E.; Shahab, A.R.; Linus, M.; Flatt, R.J.; Gramazio, F.; Kohler, M.; Langenberg, S. Complex concrete structures: Merging existing casting techniques with digital fabrication. Comput.-Aided Des. 2015 , 60 , 40–49. [ Google Scholar ] [ CrossRef ]
• Nerella, V.; Krause, M.; Näther, M.; Mechtcherine, V. 3D printing technology for on-site construction. Concr. Plant Int. 2016 , 4 , 36–41. [ Google Scholar ]
• Buswell, R.A.; De Silva, W.L.; Jones, S.Z.; Dirrenberger, J. 3D printing using concrete extrusion: A roadmap for research. Cem. Concr. Res. 2018 , 112 , 37–49. [ Google Scholar ] [ CrossRef ]
• De Schutter, G.; Feys, D. Pumping of fresh concrete: Insights and challenges. RILEM Tech. Lett. 2016 , 1 , 76–80. [ Google Scholar ] [ CrossRef ]
• Feys, D.; Khayat, K.H.; Khatib, R. How do concrete rheology, tribology, flow rate and pipe radius influence pumping pressure? Cem. Concr. Compos. 2016 , 66 , 38–46. [ Google Scholar ] [ CrossRef ]
• Mechtcherine, V.; Nerella, V.N.; Kasten, K. Testing pumpability of concrete using Sliding Pipe Rheometer. Constr. Build. Mater. 2014 , 53 , 312–323. [ Google Scholar ] [ CrossRef ]
• Nerella, V.; Näther, M.; Iqbal, A.; Butler, M.; Mechtcherine, V. Inline quantification of extrudability of cementitious materials for digital construction. Cem. Concr. Compos. 2019 , 95 , 260–270. [ Google Scholar ] [ CrossRef ]
• Jolin, M.; Burns, D.; Bissonnette, B.; Gagnon, F.; Bolduc, L.-S. Understanding the pumpability of concrete. In Proceedings of the Shotcrete for Underground Support Xl ; Engineering Conferences International; 2009; pp. 1–14. Available online: https://dc.engconfintl.org/shotcrete/17 (accessed on 21 August 2024).
• Li, L.G.; Kwan, A.K. Mortar design based on water film thickness. Constr. Build. Mater. 2011 , 25 , 2381–2390. [ Google Scholar ] [ CrossRef ]
• Li, L.G.; Kwan, A.K. Concrete mix design based on water film thickness and paste film thickness. Cem. Concr. Compos. 2013 , 39 , 33–42. [ Google Scholar ] [ CrossRef ]
• Le, T.T.; Austin, S.A.; Lim, S.; Buswell, R.A.; Law, R.; Gibb, A.G.; Thorpe, T. Hardened properties of high-performance printing concrete. Cem. Concr. Res. 2012 , 42 , 558–566. [ Google Scholar ] [ CrossRef ]
• Roussel, N.; Ovarlez, G.; Garrault, S.; Brumaud, C. The origins of thixotropy of fresh cement pastes. Cem. Concr. Res. 2012 , 42 , 148–157. [ Google Scholar ] [ CrossRef ]
• Perrot, A.; Rangeard, D.; Pierre, A. Structural built-up of cement-based materials used for 3D-printing extrusion techniques. Mater. Struct. 2016 , 49 , 1213–1220. [ Google Scholar ] [ CrossRef ]
• Marchon, D.; Kawashima, S.; Bessaies-Bey, H.; Mantellato, S.; Ng, S. Hydration and rheology control of concrete for digital fabrication: Potential admixtures and cement chemistry. Cem. Concr. Res. 2018 , 112 , 96–110. [ Google Scholar ] [ CrossRef ]
• Roussel, N. Understanding the Rheology of Concrete ; Elsevier: Amsterdam, The Netherlands, 2011. [ Google Scholar ]
• Chadegani, A.A.; Salehi, H.; Yunus, M.M.; Farhadi, H.; Fooladi, M.; Farhadi, M.; Ebrahim, N.A. A comparison between two main academic literature collections: Web of Science and Scopus databases. arXiv 2013 , arXiv:1305.0377. [ Google Scholar ] [ CrossRef ]
• Srinivasan, R.; DeFord, D.; Shah, S.P. The use of extrusion rheometry in the development of extruded fiber-reinforced cement composites. Concr. Sci. Eng. 1999 , 1 , 26–36. [ Google Scholar ]
• Kuder, K.G.; Shah, S.P. Rheology of extruded cement-based materials. ACI Mater. J. 2007 , 104 , 283. [ Google Scholar ]
• Tregger, N.A.; Pakula, M.E.; Shah, S.P. Influence of clays on the rheology of cement pastes. Cem. Concr. Res. 2010 , 40 , 384–391. [ Google Scholar ] [ CrossRef ]
• Peled, A.; Cyr, M.F.; Shah, S.P. High content of fly ash (Class F) in extruded cementitious composites. Mater. J. 2000 , 97 , 509–517. [ Google Scholar ]
• Voigt, T.; Mbele, J.-J.; Wang, K.; Shah, S.P. Using fly ash, clay, and fibers for simultaneous improvement of concrete green strength and consolidatability for slip-form pavement. J. Mater. Civ. Eng. 2010 , 22 , 196–206. [ Google Scholar ] [ CrossRef ]
• Quanji, Z.; Lomboy, G.R.; Wang, K. Influence of nano-sized highly purified magnesium alumino silicate clay on thixotropic behavior of fresh cement pastes. Constr. Build. Mater. 2014 , 69 , 295–300. [ Google Scholar ] [ CrossRef ]
• Heikal, M.; Ibrahim, N. Hydration, microstructure and phase composition of composite cements containing nano-clay. Constr. Build. Mater. 2016 , 112 , 19–27. [ Google Scholar ] [ CrossRef ]
• Qian, Y.; De Schutter, G. Enhancing thixotropy of fresh cement pastes with nanoclay in presence of polycarboxylate ether superplasticizer (PCE). Cem. Concr. Res. 2018 , 111 , 15–22. [ Google Scholar ] [ CrossRef ]
• Assaad, J.; Khayat, K.H.; Mesbah, H. Assessment of thixotropy of flowable and self-consolidating concrete. Mater. J. 2003 , 100 , 99–107. [ Google Scholar ]
• Knapen, E.; Van Gemert, D. Cement hydration and microstructure formation in the presence of water-soluble polymers. Cem. Concr. Res. 2009 , 39 , 6–13. [ Google Scholar ] [ CrossRef ]
• Yossef, M.; Chen, A. Applicability and limitations of 3D printing for civil structures. In Proceedings of the 2015 Conference on Autonomous and Robotic Construction of Infrastructure, Ames, IA, USA, 2–3 June 2015; pp. 237–246. [ Google Scholar ]
• Ding, T.; Xiao, J.; Qin, F.; Duan, Z. Mechanical behavior of 3D printed mortar with recycled sand at early ages. Constr. Build. Mater. 2020 , 248 , 118654. [ Google Scholar ] [ CrossRef ]
• Panda, B.; Lim, J.H.; Tan, M.J. Mechanical properties and deformation behaviour of early age concrete in the context of digital construction. Compos. Part B Eng. 2019 , 165 , 563–571. [ Google Scholar ] [ CrossRef ]
• Hou, S.; Duan, Z.; Xiao, J.; Ye, J. A review of 3D printed concrete: Performance requirements, testing measurements and mix design. Constr. Build. Mater. 2021 , 273 , 121745. [ Google Scholar ] [ CrossRef ]
• Makul, N. Advanced smart concrete—A review of current progress, benefits and challenges. J. Clean. Prod. 2020 , 274 , 122899. [ Google Scholar ] [ CrossRef ]
• Moelich, G.M.; Kruger, J.; Combrinck, R. Plastic shrinkage cracking in 3D printed concrete. Compos. Part B Eng. 2020 , 200 , 108313. [ Google Scholar ] [ CrossRef ]
• Tran, J.L. The law and 3D printing. John Marshall J. Inf. Technol. Priv. Law 2014 , 31 , 505. [ Google Scholar ]
• Roussel, N. Rheological requirements for printable concretes. Cem. Concr. Res. 2018 , 112 , 76–85. [ Google Scholar ] [ CrossRef ]
• Alghamdi, H.; Nair, S.A.O.; Neithalath, N. Insights into material design, extrusion rheology, and properties of 3D-printable alkali-activated fly ash-based binders. Mater. Des. 2019 , 167 , 107634. [ Google Scholar ] [ CrossRef ]
• Le, T.T.; Austin, S.A.; Lim, S.; Buswell, R.A.; Gibb, A.G.; Thorpe, T. Mix design and fresh properties for high-performance printing concrete. Mater. Struct. 2012 , 45 , 1221–1232. [ Google Scholar ] [ CrossRef ]
• Ma, G.; Li, Z.; Wang, L. Printable properties of cementitious material containing copper tailings for extrusion based 3D printing. Constr. Build. Mater. 2018 , 162 , 613–627. [ Google Scholar ] [ CrossRef ]
• Lin, T.; Jia, D.; He, P.; Wang, M.; Liang, D. Effects of fiber length on mechanical properties and fracture behavior of short carbon fiber reinforced geopolymer matrix composites. Mater. Sci. Eng. A 2008 , 497 , 181–185. [ Google Scholar ] [ CrossRef ]
• Austin, S.A.; Goodier, C.I.; Robins, P.J. Low-volume wet-process sprayed concrete: Pumping and spraying. Mater. Struct. 2005 , 38 , 229–237. [ Google Scholar ] [ CrossRef ]
• ASTM C109 ; Standard Test Method for Compressive Strength of Hydraulic Cement Mortars (using 2-in. or [50-mm] cube specimens). American Society for Testing and Material: West Conshohocken, PA, USA, 2002; pp. 1–8.
• BS EN 12390-3 ; Testing Hardened Concrete—Part 3: Compressive Strength of test Specimens. European Committee for Standardization-British Standard, 2009; pp. 1–18.
• ASTM C150 ; Standard Specification for Portland Cement. American Society for Testing and Material: West Conshohocken, PA, USA, 2007; pp. 1–6.
• GB/T 50,081 ; Standard for test methods of concrete physical and mechanical properties. Chinese Standard, 2002; pp. 1–7.
• Zhang, Y.; Zhang, Y.; Liu, G.; Yang, Y.; Wu, M.; Pang, B. Fresh properties of a novel 3D printing concrete ink. Constr. Build. Mater. 2018 , 174 , 263–271. [ Google Scholar ] [ CrossRef ]
• ASTM C403 ; Standard Test Method for Time of Setting of Concrete Mixtures by Penetration Resistance. American Society for Testing and Material: West Conshohocken, PA, USA, 2008; pp. 1–9.
• BS EN 196-9 ; Methods of testing cement—Part 9: Heat of Hydration. European Committee for Standardization-British Standard, 2010; pp. 1–20.
• ASTM C230 ; Standard Specification for Flow Table for Use in Tests of Hydraulic Cement. American Society for Testing and Material: West Conshohocken, PA, USA, 2020; pp. 1–6.
• ASTM C1437 ; Standard Test Method for Flow of Hydraulic Cement Mortar. American Society for Testing and Material: West Conshohocken, PA, USA, 2020; pp. 1–9.
• Casagrande, L.; Esposito, L.; Menna, C.; Asprone, D.; Auricchio, F. Effect of testing procedures on buildability properties of 3D-printable concrete. Constr. Build. Mater. 2020 , 245 , 118286. [ Google Scholar ] [ CrossRef ]
• ASTM C348 ; Standard Test Method for Flexural Strength of Hydraulic-Cement Mortars. American Society for Testing and Material: West Conshohocken, PA, USA, 2021; pp. 1–7.
• Van Eck, N.; Waltman, L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010 , 84 , 523–538. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Boyack, K.W.; van Eck, N.J.; Colavizza, G.; Waltman, L. Characterizing in-text citations in scientific articles: A large-scale analysis. J. Informetr. 2018 , 12 , 59–73. [ Google Scholar ] [ CrossRef ]
• Guo, Y.-M.; Huang, Z.-L.; Guo, J.; Li, H.; Guo, X.-R.; Nkeli, M.J. Bibliometric analysis on smart cities research. Sustainability 2019 , 11 , 3606. [ Google Scholar ] [ CrossRef ]
• Wolfs, R.J.M.; Bos, F.P.; Salet, T.A.M. Triaxial compression testing on early age concrete for numerical analysis of 3D concrete printing. Cem. Concr. Compos. 2019 , 104 , 103344. [ Google Scholar ] [ CrossRef ]
• Van den Heever, M.; du Plessis, A.; Bester, F.; Kruger, J.; van Zijl, G. A mechanistic evaluation relating microstructural morphology to a modified Mohr-Griffith compression-shear constitutive model for 3D printed concrete. Constr. Build. Mater. 2022 , 325 , 126743. [ Google Scholar ] [ CrossRef ]
• Van den Heever, M.; du Plessis, A.; Kruger, J.; van Zijl, G. Evaluating the effects of porosity on the mechanical properties of extrusion-based 3D printed concrete. Cem. Concr. Res. 2022 , 153 , 106695. [ Google Scholar ] [ CrossRef ]
• Kruger, J.; Cicione, A.; Bester, F.; Van den Heever, M.; Cho, S.; Walls, R.; and Van Zijl, G. Facilitating Ductile Failure of 3D Printed Concrete Elements in Fire. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Kruger, J.; Mostert, J.-P.; and Van Zijl, G. A Strain-Based Constitutive Model Ensuring Aesthetic 3D Printed Concrete Structures: Limiting Differential Settlement of Filaments. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022; RILEM Bookseries. pp. 1–10. [ Google Scholar ]
• Kruger, J.; du Plessis, A.; van Zijl, G. An investigation into the porosity of extrusion-based 3D printed concrete. Addit. Manuf. 2021 , 37 , 101740. [ Google Scholar ] [ CrossRef ]
• Kruger, J.; Zeranka, S.; van Zijl, G. 3D concrete printing: A lower bound analytical model for buildability performance quantification. Autom. Constr. 2019 , 106 , 102904. [ Google Scholar ] [ CrossRef ]
• Kruger, J.; Zeranka, S.; van Zijl, G. An ab initio approach for thixotropy characterisation of (nanoparticle-infused) 3D printable concrete. Constr. Build. Mater. 2019 , 224 , 372–386. [ Google Scholar ] [ CrossRef ]
• Kruger, J.; Zeranka, S.; van Zijl, G. A rheology-based quasi-static shape retention model for digitally fabricated concrete. Constr. Build. Mater. 2020 , 254 , 119241. [ Google Scholar ] [ CrossRef ]
• Moelich, G.M.; Janse van Rensburg, J.J.; Kruger, J.; Combrinck, R. The Environment’s Effect on the Interlayer Bond Strength of 3D Printed Concrete. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Moelich, G.M.; Kruger, J.; Combrinck, R. Modelling the interlayer bond strength of 3D printed concrete with surface moisture. Cem. Concr. Res. 2021 , 150 , 106559. [ Google Scholar ] [ CrossRef ]
• Mostert, J.-P.; Kruger, J. Interlocking 3D Printed Concrete Filaments Through Surface Topology Modifications for Improved Tensile Bond Strength. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Bester, F.; Van den Heever, M.; Kruger, J.; Cho, S.; van Zijl, G. Steel Fiber Links in 3D Printed Concrete. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Cho, S.; Kruger, J.; Bester, F.; Van den Heever, M.; Van Rooyen, A.; van Zijl, G. A Compendious Rheo-Mechanical Test for Printability Assessment of 3D Printable Concrete. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Cho, S.; Kruger, J.; Van Rooyen, A.; van Zijl, G. Rheology and application of buoyant foam concrete for digital fabrication. Compos. Part B Eng. 2021 , 215 , 108800. [ Google Scholar ] [ CrossRef ]
• Cho, S.; Van den Heever, M.; Kruger, J.; van Zijl, G. Proof-of-Concept: Sprayable SHCC Overlay Reinforcement Regime for Unreinforced 3D Printed Concrete Structure. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Cicione, A.; Kruger, J.; Walls, R.S.; Van Zijl, G. An experimental study of the behavior of 3D printed concrete at elevated temperatures. Fire Saf. J. 2021 , 120 , 103075. [ Google Scholar ] [ CrossRef ]
• Jiao, D.; Shi, C.; De Schutter, G. Magneto-rheology control in 3D concrete printing: A rheological attempt. Mater. Lett. 2022 , 309 , 131374. [ Google Scholar ] [ CrossRef ]
• Tao, Y.; Lesage, K.; Van Tittelboom, K.; Yuan, Y.; De Schutter, G. Influence of accelerator on the pore structure of 3D printable concrete. In Proceedings of the 2nd fib Italy YMG Symposium on Concrete and Concrete Structures, Roma, Italy, 18–19 November 2021; pp. 313–318. [ Google Scholar ]
• Tao, Y.; Lesage, K.; Van Tittelboom, K.; Yuan, Y.; De Schutter, G. Influence of substrate surface roughness and moisture content on tensile adhesion performance of 3D printable concrete. Cem. Concr. Compos. 2022 , 126 , 104350. [ Google Scholar ] [ CrossRef ]
• Tao, Y.; Ren, Q.; Lesage, K.; Van Tittelboom, K.; Yuan, Y.; De Schutter, G. Shape stability of 3D printable concrete with river and manufactured sand characterized by squeeze flow. Cem. Concr. Compos. 2022 , 133 , 104674. [ Google Scholar ] [ CrossRef ]
• Tao, Y.; Lesage, K.; Van Tittelboom, K.; Yuan, Y.; De Schutter, G. Effect of Limestone Powder Substitution on Fresh and Hardened Properties of 3D Printable Mortar. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Mohan, M.K.; Rahul, A.V.; De Schutter, G.; Van Tittelboom, K. Salt Scaling Resistance of 3D Printed Concrete. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Mohan, M.K.; Rahul, A.V.; Van Dam, B.; Zeidan, T.; De Schutter, G.; Van Tittelboom, K. Performance criteria, environmental impact and cost assessment for 3D printable concrete mixtures. Resour. Conserv. Recycl. 2022 , 181 , 106255. [ Google Scholar ] [ CrossRef ]
• Tao, Y.; Rahul, A.V.; Lesage, K.; Van Tittelboom, K.; Yuan, Y.; De Schutter, G. Mechanical and microstructural properties of 3D printable concrete in the context of the twin-pipe pumping strategy. Cem. Concr. Compos. 2022 , 125 , 104324. [ Google Scholar ] [ CrossRef ]
• Tao, Y.; Rahul, A.V.; Mohan, M.K.; Van Tittelboom, K.; Yuan, Y.; De Schutter, G. Blending performance of helical static mixer used for twin-pipe 3D concrete printing. Cem. Concr. Compos. 2022 , 134 , 104741. [ Google Scholar ] [ CrossRef ]
• Rahul, A.V.; Mohan, M.K.; De Schutter, G.; Van Tittelboom, K. 3D printable concrete with natural and recycled coarse aggregates: Rheological, mechanical and shrinkage behaviour. Cem. Concr. Compos. 2022 , 125 , 104311. [ Google Scholar ] [ CrossRef ]
• Mohan, M.K.; Rahul, A.V.; Van Tittelboom, K.; De Schutter, G. Evaluating the Influence of Aggregate Content on Pumpability of 3D Printable Concrete. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Mohan, M.K.; Rahul, A.V.; De Schutter, G.; Van Tittelboom, K. Early age hydration, rheology and pumping characteristics of CSA cement-based 3D printable concrete. Constr. Build. Mater. 2021 , 275 , 122136. [ Google Scholar ] [ CrossRef ]
• Mohan, M.K.; Rahul, A.V.; Tao, Y.; De Schutter, G.; Van Tittelboom, K. Hydration re-initiation of borated CSA systems with a two-stage mixing process: An application in extrusion-based concrete 3D printing. Cem. Concr. Res. 2022 , 159 , 106870. [ Google Scholar ] [ CrossRef ]
• Ooms, T.; Vantyghem, G.; Tao, Y.; Bekaert, M.; De Schutter, G.; Van Tittelboom, K.; De Corte, W. The Production of a Topology-Optimized 3D-Printed Concrete Bridge. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Jayathilakage, R.I.; Rajeev, P.; Sanjayan, J. Predication of Strength-Based Failure in Extrusion-Based 3D Concrete Printing. In Proceedings of the Rheology and Processing of Construction Materials: RheoCon2 & SCC9, Dresden, Germany, 8–11 September 2019. RILEM Bookseries. [ Google Scholar ]
• Jayathilakage, R.; Rajeev, P.; Sanjayan, J. Yield stress criteria to assess the buildability of 3D concrete printing. Constr. Build. Mater. 2020 , 240 , 117989. [ Google Scholar ] [ CrossRef ]
• Jayathilakage, R.; Rajeev, P.; Sanjayan, J. Extrusion rheometer for 3D concrete printing. Cem. Concr. Compos. 2021 , 121 , 104075. [ Google Scholar ] [ CrossRef ]
• Jayathilakage, R.; Sanjayan, J.; Rajeev, P. Direct shear test for the assessment of rheological parameters of concrete for 3D printing applications. Mater. Struct. 2019 , 52 , 12. [ Google Scholar ] [ CrossRef ]
• Jayathilakage, R.; Sanjayan, J.; Rajeev, P. Characterizing Extrudability for 3D Concrete Printing Using Discrete Element Simulations. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Muthukrishnan, S.; Ramakrishnan, S.; Sanjayan, J. Effect of alkali reactions on the rheology of one-part 3D printable geopolymer concrete. Cem. Concr. Compos. 2021 , 116 , 103899. [ Google Scholar ] [ CrossRef ]
• Pham, L.; Tran, P.; Sanjayan, J. Steel fibres reinforced 3D printed concrete: Influence of fibre sizes on mechanical performance. Constr. Build. Mater. 2020 , 250 , 118785. [ Google Scholar ] [ CrossRef ]
• Ramakrishnan, S.; Kanagasuntharam, S.; Sanjayan, J. In-line activation of cementitious materials for 3D concrete printing. Cem. Concr. Compos. 2022 , 131 , 104598. [ Google Scholar ] [ CrossRef ]
• Xia, M.; Nematollahi, B.; Sanjayan, J. Influence of binder saturation level on compressive strength and dimensional accuracy of powder-based 3D printed geopolymer. Mater. Sci. Forum 2018 , 939 , 177–183. [ Google Scholar ] [ CrossRef ]
• Xia, M.; Nematollahi, B.; Sanjayan, J.G. Properties of Powder-Based 3D Printed Geopolymers. In 3D Concrete Printing Technology: Construction and Building Applications ; Butterworth-Heinemann: Oxford, UK, 2019. [ Google Scholar ]
• Yu, S.; Xia, M.; Sanjayan, J.; Yang, L.; Xiao, J.; Du, H. Microstructural characterization of 3D printed concrete. J. Build. Eng. 2021 , 44 , 102948. [ Google Scholar ] [ CrossRef ]
• Nematollahi, B.; Bong, S.H.; Xia, M.; Sanjayan, J. Digital Fabrication of ‘Just-Add-Water’ Geopolymers: Effects of Curing Condition and Print-Time Interval. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Bai, G.; Wang, L.; Ma, G.; Sanjayan, J.; Bai, M. 3D printing eco-friendly concrete containing under-utilised and waste solids as aggregates. Cem. Concr. Compos. 2021 , 120 , 104037. [ Google Scholar ] [ CrossRef ]
• Li, Z.; Ma, G.; Wang, F.; Wang, L.; Sanjayan, J. Expansive cementitious materials to improve micro-cable reinforcement bond in 3D concrete printing. Cem. Concr. Compos. 2022 , 125 , 104304. [ Google Scholar ] [ CrossRef ]
• Arunothayan, A.R.; Nematollahi, B.; Sanjayan, J.; Ranade, R.; Bong, S.H.; Khayat, K. Quantitative Evaluation of Orientation of Steel Fibers in 3D-Printed Ultra-High Performance Concrete. In Proceedings of the Second RILEM International Conference on Concrete and Digital Fabrication: Digital Concrete, Eindhoven, The Netherlands, 6–9 July 2020. RILEM Bookseries. [ Google Scholar ]
• Marchment, T.; Xia, M.; Dodd, E.; Sanjayan, J.; Nematollahi, B. Effect of delay time on the mechanical properties of extrusion-based 3D printed concrete. In Proceedings of the ISARC 2017—34th International Symposium on Automation and Robotics in Construction, Taipei, Taiwan, 28 June–1 July 2017; pp. 240–245. [ Google Scholar ]
• Christen, H.; van Zijl, G.; de Villiers, W. The incorporation of recycled brick aggregate in 3D printed concrete. Clean. Mater. 2022 , 4 , 100090. [ Google Scholar ] [ CrossRef ]
• Christen, H.; Cho, S.; van Zijl, G.; de Villiers, W. Phase change material infused recycled brick aggregate in 3D printed concrete. Heliyon 2022 , 8 , e11598. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Cho, S.; Van Rooyen, A.; Kearsley, E.; Van Zijl, G. Foam stability of 3D printable foamed concrete. J. Build. Eng. 2022 , 47 , 103884. [ Google Scholar ] [ CrossRef ]
• Xiao, J.Z.; Liu, H.R.; Ding, T.; Ma, G.W. 3D printed concrete components and structures: An overview. Sustain. Struct. 2021 , 1 , 1–15. [ Google Scholar ] [ CrossRef ]
• Sun, J.; Aslani, F.; Lu, J.; Wang, L.; Huang, Y.; Ma, G. Fibre-reinforced lightweight engineered cementitious composites for 3D concrete printing. Ceram. Int. 2021 , 47 , 27107–27121. [ Google Scholar ] [ CrossRef ]
• Cui, T. Effect of HB-CSA and Expansion Agent on Shrinkage and Cracking Performance of 3D Printing Concret. Cailiao Daobao/Mater. Rep. 2022 , 36 , 80–86. [ Google Scholar ]
• Wang, L.; Ma, G.; Liu, T.; Buswell, R.; Li, Z. Interlayer reinforcement of 3D printed concrete by the in-process deposition of U-nails. Cem. Concr. Res. 2021 , 148 , 106535. [ Google Scholar ] [ CrossRef ]
• Wang, L.; Xiao, W.; Wang, Q.; Jiang, H.; Ma, G. Freeze-thaw resistance of 3D-printed composites with desert sand. Cem. Concr. Compos. 2022 , 133 , 104693. [ Google Scholar ] [ CrossRef ]
• Wang, L.; Tian, Z.; Ma, G.; Zhang, M. Interlayer bonding improvement of 3D printed concrete with polymer modified mortar: Experiments and molecular dynamics studies. Cem. Concr. Compos. 2020 , 110 , 103571. [ Google Scholar ] [ CrossRef ]
• Ma, G.; Li, Z.; Wang, L.; Bai, G. Micro-cable reinforced geopolymer composite for extrusion-based 3D printing. Mater. Lett. 2019 , 235 , 144–147. [ Google Scholar ]
• Li, Z.; Wang, L.; Ma, G. Mechanical improvement of continuous steel microcable reinforced geopolymer composites for 3D printing subjected to different loading conditions. Compos. Part B Eng. 2020 , 187 , 107796. [ Google Scholar ] [ CrossRef ]
• Bai, G.; Wang, L.; Wang, F.; Ma, G. In-process reinforcing method: Dual 3D printing procedure for ultra-high performance concrete reinforced cementitious composites. Mater. Lett. 2021 , 304 , 130594. [ Google Scholar ] [ CrossRef ]
• Wang, L.; Yang, Y.; Yao, L.; Ma, G. Interfacial bonding properties of 3D printed permanent formwork with the post-casted concrete. Cem. Concr. Compos. 2022 , 128 , 104457. [ Google Scholar ] [ CrossRef ]
• Liu, M.; Zhang, Q.; Tan, Z.; Wang, L.; Li, Z.; Ma, G. Investigation of steel wire mesh reinforcement method for 3D concrete printing. Arch. Civ. Mech. Eng. 2021 , 21 , 24. [ Google Scholar ] [ CrossRef ]
• Ma, G.; Salman, N.M.; Wang, L.; Wang, F. A novel additive mortar leveraging internal curing for enhancing interlayer bonding of cementitious composite for 3D printing. Constr. Build. Mater. 2020 , 244 , 118305. [ Google Scholar ] [ CrossRef ]
• Sun, J.; Huang, Y.; Aslani, F.; Ma, G. Properties of a double-layer EMW-absorbing structure containing a graded nano-sized absorbent combing extruded and sprayed 3D printing. Constr. Build. Mater. 2020 , 261 , 120031. [ Google Scholar ] [ CrossRef ]
• Saelens, L.; Van Tittelboom, K.; Caspeele, R.; Wan-Wendner, R. Topology optimization of structural beam systems considering 3D concrete printing technology constraints. In Proceedings of the 4th International PhD Symposium in Civil Engineering, Rome, Italy, 5–7 September 2022; Volume 58, pp. 825–832. [ Google Scholar ]
• Wang, L.; Liu, Y.; Yang, Y.; Li, Y.; Bai, M. Bonding performance of 3D printing concrete with self-locking interfaces exposed to compression–shear and compression–splitting stresses. Addit. Manuf. 2021 , 42 , 101992. [ Google Scholar ] [ CrossRef ]
• Wang, L.; Lin, W.; Ma, H.; Li, D.; Wang, Q. Mechanical and microstructural properties of 3D-printed aluminate cement based composite exposed to elevated temperatures. Constr. Build. Mater. 2022 , 353 , 129144. [ Google Scholar ] [ CrossRef ]
• Zhang, C.; Hou, Z.; Chen, C.; Zhang, Y.; Mechtcherine, V.; Sun, Z. Design of 3D printable concrete based on the relationship between flowability of cement paste and optimum aggregate content. Cem. Concr. Compos. 2019 , 104 , 103406. [ Google Scholar ] [ CrossRef ]
• Zhang, C.; Jia, Z.; Wang, X.; Jia, L.; Deng, Z.; Wang, Z.; Zhang, Y.; Mechtcherine, V. A two-phase design strategy based on the composite of mortar and coarse aggregate for 3D printable concrete with coarse aggregate. J. Build. Eng. 2022 , 54 , 104672. [ Google Scholar ] [ CrossRef ]
• Zhang, C.; Deng, Z.; Chen, C.; Zhang, Y.; Mechtcherine, V.; Sun, Z. Predicting the static yield stress of 3D printable concrete based on flowability of paste and thickness of excess paste layer. Cem. Concr. Compos. 2022 , 129 , 104494. [ Google Scholar ] [ CrossRef ]
• Liu, H.; Ding, T.; Xiao, J.; Mechtcherine, V. Buildability prediction of 3D–printed concrete at early-ages: A numerical study with Drucker–Prager model. Addit. Manuf. 2022 , 55 , 102821. [ Google Scholar ] [ CrossRef ]
• Markin, S.; Mechtcherine, V. Measuring Plastic Shrinkage and Related Cracking of 3D Printed Concretes. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Schröfl, C.; Nerella, V.N.; Mechtcherine, V. Capillary water intake by 3D-printed concrete visualised and quantified by neutron radiography. In First RILEM International Conference on Concrete and Digital Fabrication–Digital Concrete 2018 ; Springer: Berlin/Heidelberg, Germany, 2019; RILEM Bookseries. [ Google Scholar ]
• Ghourchian, S.; Butler, M.; Krüger, M.; Mechtcherine, V. Modelling the development of capillary pressure in freshly 3D-printed concrete elements. Cem. Concr. Res. 2021 , 145 , 106457. [ Google Scholar ] [ CrossRef ]
• Taubert, M.; Mechtcherine, V. Mix Design for a 3D-Printable Concrete with Coarse Aggregates and Consideration of Standardisation. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Mechtcherine, V.; Nerella, V.N.; Ogura, H.; Grafe, J.; Spaniol, E.; Hertel, M.; Füssel, U. Alternative reinforcements for digital concrete construction. In First RILEM International Conference on Concrete and Digital Fabrication–Digital Concrete 2018 ; Springer: Berlin/Heidelberg, Germany, 2019; RILEM Bookseries. [ Google Scholar ]
• Reißig, S.; Nerella, V.N.; Mechtcherine, V. Material Design and Rheological Behavior of Sustainable Cement-Based Materials in the Context of 3D Printing. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Neef, T.; Müller, S.; Mechtcherine, V. Integration of Mineral Impregnated Carbon Fibre (MCF) into Fine 3D-Printed Concrete Filaments. In Proceedings of the RILEM International Conference on Concrete and Digital Fabrication, Loughborough, UK, 27–29 June 2022. RILEM Bookseries. [ Google Scholar ]
• Costanzi, C.B.; Ahmed, Z.Y.; Schipper, H.R.; Bos, F.P.; Knaack, U.; Wolfs, R.J.M. 3D Printing Concrete on temporary surfaces: The design and fabrication of a concrete shell structure. Autom. Constr. 2018 , 94 , 395–404. [ Google Scholar ] [ CrossRef ]
• Hass, L.; Bos, F.P.; Salet, T.A.M. Characterizing the bond properties of automatically placed helical reinforcement in 3D printed concrete. Constr. Build. Mater. 2022 , 355 , 129228. [ Google Scholar ] [ CrossRef ]
• Wolfs, R.J.M.; Bos, F.P.; Salet, T.A.M. Correlation between destructive compression tests and non-destructive ultrasonic measurements on early age 3D printed concrete. Constr. Build. Mater. 2018 , 181 , 447–454. [ Google Scholar ] [ CrossRef ]
• Wolfs, R.J.M.; Bos, F.P.; Salet, T.A.M. Hardened properties of 3D printed concrete: The influence of process parameters on interlayer adhesion. Cem. Concr. Res. 2019 , 119 , 132–140. [ Google Scholar ] [ CrossRef ]
• Salet, T.A.; Ahmed, Z.Y.; Bos, F.P.; Laagland, H.L. 3D printed concrete bridge. In Proceedings of the International Conference on Progress in Additive Manufacturing, Singapore, 14–17 May 2018; pp. 2–9. [ Google Scholar ]
• Salet, T.A.; Ahmed, Z.Y.; Bos, F.P.; Laagland, H.L. Design of a 3D printed concrete bridge by testing. Virtual Phys. Prototyp. 2018 , 13 , 222–236. [ Google Scholar ] [ CrossRef ]
• Bos, F.P.; Ahmed, Z.Y.; Jutinov, E.R.; Salet, T.A. Experimental exploration of metal cable as reinforcement in 3D printed concrete. Materials 2017 , 10 , 1314. [ Google Scholar ] [ CrossRef ]
• Bos, F.P.; Bosco, E.; Salet, T.A.M. Ductility of 3D printed concrete reinforced with short straight steel fibers. Virtual Phys. Prototyp. 2019 , 14 , 160–174. [ Google Scholar ] [ CrossRef ]
• Ahmed, Z.Y.; Bos, F.P.; Van Brunschot, M.C.A.J.; Salet, T.A. On-demand additive manufacturing of functionally graded concrete. Virtual Phys. Prototyp. 2020 , 15 , 194–210. [ Google Scholar ] [ CrossRef ]
• Bhattacherjee, S.; Basavaraj, A.S.; Rahul, A.V.; Santhanam, M.; Gettu, R.; Panda, B.; Schlangen, E.; Chen, Y.; Copuroglu, O.; Ma, G.; et al. Sustainable materials for 3D concrete printing. Cem. Conc. Composites. J. 2021 , 122 , 104156. [ Google Scholar ] [ CrossRef ]
• Rahul, A.V.; Santhanam, M. Evaluating the printability of concretes containing lightweight coarse aggregates. Cem. Concr. Compos. 2020 , 109 , 103570. [ Google Scholar ] [ CrossRef ]
• Quah, T.K.N.; Yi, W.D.T.; Jian, H.L.; Ming, J.T.; Teck, N.W.; King, H.H.L. Concrete 3D printing: Process parameters for process control, monitoring and diagnosis in automation and construction. Mathematics 2023 , 11 , 1499. [ Google Scholar ] [ CrossRef ]

Click here to enlarge figure

Share and Cite

Huseien, G.F.; Tan, S.Q.; Saleh, A.T.; Lim, N.H.A.S.; Ghoshal, S.K. Test Procedures and Mechanical Properties of Three-Dimensional Printable Concrete Enclosing Different Mix Proportions: A Review and Bibliometric Analysis. Buildings 2024 , 14 , 2667. https://doi.org/10.3390/buildings14092667

Huseien GF, Tan SQ, Saleh AT, Lim NHAS, Ghoshal SK. Test Procedures and Mechanical Properties of Three-Dimensional Printable Concrete Enclosing Different Mix Proportions: A Review and Bibliometric Analysis. Buildings . 2024; 14(9):2667. https://doi.org/10.3390/buildings14092667

Huseien, Ghasan Fahim, Shea Qin Tan, Ali Taha Saleh, Nor Hasanah Abdul Shukor Lim, and Sib K. Ghoshal. 2024. "Test Procedures and Mechanical Properties of Three-Dimensional Printable Concrete Enclosing Different Mix Proportions: A Review and Bibliometric Analysis" Buildings 14, no. 9: 2667. https://doi.org/10.3390/buildings14092667

Article Metrics

Article access statistics, further information, mdpi initiatives, follow mdpi.

Subscribe to receive issue release notifications and newsletters from MDPI journals